<SEC-DOCUMENT>0001193125-11-260265.txt : 20110930
<SEC-HEADER>0001193125-11-260265.hdr.sgml : 20110930
<ACCEPTANCE-DATETIME>20110929184648
ACCESSION NUMBER:		0001193125-11-260265
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20110928
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110930
DATE AS OF CHANGE:		20110929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30489
		FILM NUMBER:		111115458

	BUSINESS ADDRESS:	
		STREET 1:		11545 WEST BERNARDO COURT
		STREET 2:		SUITE 301
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92127
		BUSINESS PHONE:		858-312-8000

	MAIL ADDRESS:	
		STREET 1:		11545 WEST BERNARDO COURT
		STREET 2:		SUITE 301
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d238735d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of Earliest Event Reported): September&nbsp;28, 2011 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>Lifevantage Corporation </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact Name of Registrant as Specified in Charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Colorado</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-30489</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>90-0224471</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or Other Jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of Incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11545 W. Bernardo Court, Suite 301, San Diego, California</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>92127</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of Principal Executive Offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s Telephone Number, Including Area Code: (858)&nbsp;312-8000 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Former Name or Former Address, if Changed Since Last Report)
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;7.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Regulation FD Disclosure. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Douglas C. Robinson, President and Chief Executive Officer of Lifevantage Corporation (the &#147;Company&#148;), and Carrie McQueen, the
Company&#146;s Chief Financial Officer, held a telephone conference call which was open to the public on September&nbsp;29, 2011. A copy of the transcript of the conference call is attached as Exhibit 99.1. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In accordance with General Instruction B.2 of Form 8-K, the foregoing information, including Exhibit 99.1, shall not be deemed
&#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information, including Exhibit 99.1, be deemed incorporated by reference into any
filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The information contained in the transcript is intended to be considered in the context of the Company&#146;s filings with the Securities and Exchange Commission (the &#147;SEC&#148;) and other public
announcements that the Company makes, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as
its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:25pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit<BR>No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings Call Transcript dated September&nbsp;28, 2011</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-2-
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dated: September&nbsp;29, 2011</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lifevantage Corporation</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Carrie E. McQueen</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Carrie E. McQueen</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer, Secretary &amp; Treasurer</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-3-
</FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d238735dex991.htm
<DESCRIPTION>EARNINGS CALL TRANSCRIPT
<TEXT>
<HTML><HEAD>
<TITLE>Earnings Call Transcript</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="right"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px">


<IMG SRC="g238735ex99_1pg001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Conference Call Transcript </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>LFVN - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Event Date/Time: Sep 28, 2011
/ 02:30PM GMT </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CORPORATE PARTICIPANTS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>John Mills </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>IRC - Corporate Communications </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Doug Robinson </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>LifeVantage
Corporation - President and CEO </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>LifeVantage Corporation - CFO </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>David Brown </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>LifeVantage Corporation - President of LifeVantage Network </I></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CONFERENCE CALL PARTICIPANTS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Steve Wymer </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Bolt Capital - Analyst </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stewart Flink
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Next View Capital - Analyst </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Jim Galloway </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Galloway Enterprises, Inc. - Analyst </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Melanie Hillam </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Analyst
</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dan Wurtz </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Analyst
</I></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PRESENTATION </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operator </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Good day, ladies and gentlemen. Thank you for standing by. Welcome to today&#146;s LifeVantage fourth-quarter 2011 earnings conference call. At this time
all participants are in a listen-only mode. Following the formal remarks, we will conduct a question-and-answer session. Instructions will be provided at that time for you to queue up. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Hosting today&#146;s conference will be John Mills with ICR. As a reminder, today&#146;s conference is being recorded. And now I would like to turn the conference over to Mr.&nbsp;Mills. Please go ahead,
sir. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>John Mills</B> <B>- </B><B><I>IRC - Corporate Communications</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thank you.
Good afternoon, ladies and gentlemen, and welcome to LifeVantage&#146;s fiscal fourth-quarter 2011 conference call. I am with ICR, the largest independent financial communications firm in North America with offices in New York, Connecticut, Boston,
Los Angeles, San Francisco and Beijing, China. My team is solely focused on healthy living and healthcare companies and we will be supporting LifeVantage&#146;s management team and Director of Investor Relations and their Investor Relations efforts.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On the call today from LifeVantage are Doug Robinson, Chief Executive Officer, Carrie McQueen, Chief Financial Officer, as well as David
Brown, President of LifeVantage Network. By now, everyone should have access to the earnings release which went out this afternoon at approximately 4 PM Eastern time. If you&#146;ve not received the release, it is available on the Investor Relations
portion of LifeVantage&#146;s website at www.LifeVantage.com. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This call is being webcast and a replay will be available on the Company&#146;s
website as well. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Before we begin, we would like to remind everyone that the prepared remarks contain forward-looking
statements and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance and therefore undue reliance should not be placed upon them. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">These statements are based on current expectations of management and involve inherent risks and uncertainties including those identified in the Risk
Factors section of LifeVantage&#146;s most recently filed 10-Q and 10-K. These risk factors contain a more detailed discussion of the factors that could cause actual results to differ materially from those projected in any forward-looking
statements. LifeVantage assumes no obligation to update any forward-looking projections that may be made in today&#146;s release or call. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">And
with that, I would like to turn the call over to the Company&#146;s CEO, Mr.&nbsp;Doug Robinson. Go ahead, Doug. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Doug Robinson - </B><B><I>LifeVantage
Corporation - President and CEO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thanks, John. Good afternoon, everyone, and welcome to our fiscal fourth-quarter 2011
conference call. On today&#146;s call, I will provide some highlights of our record fourth-quarter results. Then I will provide a general update on our business and highlight growth initiatives for fiscal 2012 and beyond. And then Carrie McQueen
will follow the financial results for the fourth quarter and full fiscal year 2011 in more detail and provide our outlook for the full-year fiscal 2012. I will provide some closing remarks and we will open up the call for questions that Carrie,
David, and I will field. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">First, let me refer to our financial overview. We finished fiscal 2011 on a very strong note as we generated record
results for both revenue and operating income. For the fourth quarter of fiscal 2011, we achieved net revenue of approximately $15 million which is a 241% increase compared with the same period last year, and an increase of 50% on a sequential basis
compared with the third fiscal quarter ended March&nbsp;31, 2011. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the fourth quarter, we generated approximately $2 million in operating
income compared to a loss of approximately $290,000 for the same period last year. This is the fourth consecutive quarter we&#146;ve achieved positive operating income, a streak we&#146;re very proud of and we&#146;re confident that will continue.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Also, we generated approximately $2.2 million in operating cash flow for the fourth fiscal quarter. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Turning briefly to our full-year results, in fiscal 2011 we generated net revenue of $38.9 million, an increase of 238% compared to fiscal 2010. Our
operating income for fiscal 2011 was $3.7 million, an $11 million positive swing from an operating loss of $7.3 million last year. Our financial performance in fiscal 2011 and guidance for fiscal 2012 underscores the expanding awareness of our
products and the strong pipeline of businesses we are building. We continue to benefit from new independently published studies that outline the efficacy of Protandim and further bolster the science behind it. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are also are benefiting from a rapidly increasing number of studies about the Nrf2 molecule, the biochemical messenger that is activated by Protandim.
Approximately 600 studies per year are being conducted about Nrf2, which is double the rate of just three years ago. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For those of you that
are new to our business, let me provide a brief overview of the science behind our product offerings, Protandim and TrueScience. Protandim is a dietary supplement that is comprised of a unique patented blend of naturally occurring plant compounds.
We believe what makes Protandim so powerful and important to our health is its ability to activate the Nrf2 molecule, known as the master regulator of the antioxidant response in the molecule that controls the set of genes sometimes referred to as
survival genes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Protandim has been demonstrated to activate the Nrf2 molecule which helps our bodies combat what is known as oxidative
stress. Oxidative stress is cellular and tissue damage caused by chemically reactive oxygen radicals formed as a natural consequence of cellular metabolism. This type of damage to your body cells by free radicals is believed to be the root cause at
the cellular level of aging and many age-related diseases. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Diseases linked to oxidative stress include Parkinson&#146;s disease, heart
failure, cardiovascular disease, myocardial infarction, Alzheimer&#146;s disease, schizophrenia, bipolar disorder, chronic fatigue system syndrome and cancer, to name but a few. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our bodies already contain the information for how to effectively combat stressful situations, such as oxidative stress and chronic inflammation. That information is stored in our genes. The secret lies
in being able to instruct cells regarding the implementation of that information. This is what Protandim has been shown to do through the activation of the Nrf2 molecule. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The final point about Protandim that is worth highlighting is that it is free of any substances banned
by such organizations as the International Olympic Committee, the NCAA and the NFL. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">LifeVantage TrueScience is the first product we created
for expansion into a family of products that remains focused on attacking oxidative stress internally and externally. LifeVantage TrueScience anti-aging cream is a unique, scientifically based skin care products formulated to protect the skin from
factors that contribute to aging and unhealthy skin. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">LifeVantage TrueScience contains similar ingredients to those found in Protandim. It has
been formulated to improve skin tone and coloring, it diminishes the appearance of fine lines and wrinkles, and provides a vibrant healthy appearance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">LifeVantage TrueScience is also designed to improve skin texture and pigmentation while increasing moisture. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Awareness and understanding about Protandim and LifeVantage TrueScience is expanding in consumer markets as well as among medical professionals. However, while we are certainly very proud of our strong
growth in fiscal 2011, we believe we&#146;ve only begun to realize their potential. Looking toward fiscal 2012 and beyond, we&#146;re committed to taking the necessary steps to ensure that we have the right infrastructure and resources in place for
long-term sustainable growth. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are now at an important time in the maturation of LifeVantage. In past years, we were focused on survival
and operating in the leanest manner possible. As we make the shift from being a young small company in its development phase to a rapidly growing medium-sized company, we believe it is prudent to make key investments in both our operating expenses
and capital expenditures to ensure that we can capitalize on the robust opportunities ahead of us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to position ourselves to execute
on key growth initiatives, we will be proactive in both our strategic planning and tactical execution. Importantly, we will also maintain a nimble mind set and make adjustments with respect to timing and other factors, if necessary. While we will be
investing in our growth, we will continue to be mindful of our operating income and focus on continuing to improve our financial performance, including higher operating margins in fiscal 2012 compared to fiscal 2011. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">One key area of investment will be our personnel growth and development. As many of you have seen, in June we announced that we strengthened our
management team with the appointment of Dr.&nbsp;Joe McCord, renowned scientist, codiscoverer of superoxide dismutase and a pioneer in the area of free radical biology, as our Chief Science Officer. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">While Dr.&nbsp;McCord has been involved with LifeVantage for years, his increased involvement with the Company will be extremely beneficial as we work
towards expanding the understanding of our products to existing and potential new customers. We also announced the reappointment of Dr.&nbsp;Brooks Hybertson, a nationally recognized oxidative stress researcher, to our Scientific Advisory Board.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the leadership of Doctors McCord and Hybertson, we will be supporting new research and development studies. The increased daily
involvement of both doctors will be important as we work on expanding our product portfolio with complementary products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will also be
strategically investing in human resources in other departments to ensure we have the appropriate resources to handle our growing business in areas such as finance, marketing and sales. As we expand our team, we will be mindful of maintaining the
appropriate corporate culture and efficient infrastructure. As an example we recently retained ICR and hired an internal Director of Investor Relations to help facilitate growing shareholder interest. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Another key area of investment in fiscal 2012 will be our sales initiative. Under David Brown&#146;s leadership, we&#146;ve had great success within our
network marketing operations in the past year. In April, we had over 2,000 distributors attend our inaugural global network marketing convention, and in July we held a quarterly Elite Academy that over 2,500 distributors attended. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The strong attendance at both of these events underscores the interest and enthusiasm about our products from a growing number of people. And we
anticipate that our distributor events will increase significantly in size next year. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to help our distributors build their
businesses, we are implementing several strategies that serve as the basis for our sales initiatives during fiscal 2012. First, we refined our distributor training in sales meetings strategy. We know that regular sales meetings and trainings build
momentum and growth throughout the distributor base. We know that sales presentations translate directly to new enrollment revenue and ongoing monthly autoship revenue. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Last year, we focused on responding to areas of the country which had the greatest concentration of
distributors and on helping our top distributors attain their current elite ranks. This year, we will be increasingly focusing on building our mid-level ranks and working with them to advance in rank until achieving an elite rank status. In doing
this, we will develop a larger middle class of distributors who are building large sales organizations and receiving significant monthly commission checks. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">This will create more distributor leaders in our distributor base and help even more distributors achieve the financial success they are striving for. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Second, we are increasing the number of training events we conduct. Each month we are adding more locations for our premier schools and Super Saturdays.
These monthly meetings are sponsored by LifeVantage but hosted and conducted by elite level distributors. They provide valuable hands-on training by those who have already achieved significant success with the Company and serve to motivate and spur
the growth in distributors in every location in which they are held. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We&#146;ve also added a CD audio training series to our Vantage Packs
and made them available in monthly autoship orders. So distributors can review information given at Elite Academies and other events wherever and whenever they would prefer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Third, we are bolstering our distributor recognition program. We have found that money invested in recognizing distributor efforts generates increased activity and loyalty by our distributors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lastly, customer service will remain a key focus this year since we know that it&#146;s easier to keep a customer than to find a new one. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additionally, we&#146;re implementing a new customer retention program aimed at further increasing our already high customer and distributor retention
rates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">While the US is our largest market and most of the &#151; most of our investments in our sales initiatives will be here, we are also
making selective and strategic investments to grow our business in other countries. The opportunity in Japan is very encouraging so we are making appropriate investments to educate and grow our distributor base in Japan. Over the next few years we
expect to be selling our products in a growing number of countries and as we see necessary we will increase our investment in each country on a case-by-case basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To complement our initiatives to grow our distributor base, we are also making strategic marketing investments to increase the awareness of Protandim and TrueScience. Last week, we announced that Donny
Osmond is now acting as spokesperson for Protandim. Donny is truly an ideal person to endorse their product. With a career that spans over five decades, Donny is famous for not only his music but also his youthful appearance. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">I would be remiss if I did not highlight that Donny recently won Dancing With the Stars, making him the oldest celebrity ever to win the show. Donny
began using Protandim in 2009 as part of his health regimen per his doctor&#146;s recommendation and he now attributes Protandim as one of the reasons that he continues to look and feel young. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are very excited about our relationship with Donny. His personal experience, together with his celebrity status, should enable him to tell the world
why activating Nrf2 and reducing oxidative stress linked to numerous health conditions is so important. As we work to expand our product portfolio we will focus on compelling and innovative products backed by science that activate Nrf2 and combat
oxidative stress. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In summary, fiscal 2011 was a great year for LifeVantage and we believe fiscal 2012 will be even better. Even as we are
making these investments into our Company, we believe that we will be able to improve the leverage in our business and grow our operating margin in fiscal 2012. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Also, the investments we are making into our business as I outlined earlier will enable us to greatly expand our reach and our message. This will not only benefit our business and enhance our shareholder
value, but it will also help us achieve our ultimate goal &#151; educating people around the world about a simple, safe and effective way to enhance their health and wellness. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Now I will turn the call over to Carrie to review our financial results. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen - </B><B><I>LifeVantage
Corporation - CFO</I></B><B> </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thank you, Doug. As Doug said we are very pleased with our fourth quarter and full year fiscal 2011
financial performance. We&#146;re proud to be reporting our 10th consecutive quarter of net revenue growth and, importantly, this also marks our fourth consecutive quarter of generating operating income. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Let me review our results in more detail. In the fourth fiscal quarter of 2011, we generated record net revenue of approximately $15 million which
represents a 241% increase from the fourth fiscal quarter of 2010. On a sequential basis, our revenue increased 50% from $10 million in the third quarter of fiscal 2011. Gross profit in fiscal Q4 of 2011 increased to $12.9 million from $3.7 million
in fiscal Q4 2010, reflecting our higher sales. Gross margins improved to 86%. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating expenses for the fourth fiscal quarter of 2011 were
$11 million compared to $4 million for the same period last year. On a sequential basis, operating expenses increased 45% from $7.6 million in the third fiscal quarter of 2011. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The increases in both periods are due primarily to increased sales commissions, which are a direct result of our increased revenue and in addition to greater investments in personnel and infrastructure to
position ourselves for future growth. As we take the necessary steps to position LifeVantage for long-term growth, we anticipate that our operating expenses will continue to increase in coming quarters. But we also believe we will be able to
leverage these investments and achieve a greater operating margin in fiscal 2012 compared to fiscal 2011. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales and marketing expenses
increased to $8.3 million in fiscal 2011 from $2.6 million in Q4 2010 and from $5.4 million in fiscal Q3 2011. The increases in both periods are primarily due to commissions paid to distributors due to the higher sales volume. We expect sales and
marketing expense will continue to increase along with our revenue growth. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the fourth fiscal quarter of 2011, general and administrative
expenses increased to $2.4 million from $1.2 million in the fourth fiscal quarter last year and from $2.1 million the third fiscal quarter of 2011. The increase reflects higher personnel costs related to our expanding operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect general and administrative expense to remain relatively stable in coming quarters although there may be some periodic increases associated with
higher employee costs as we build infrastructure to support the rapidly expanding business. Our research and development costs increased to $194,000 from $97,000 in the prior year period and from $70,000 in Q3 2011. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As Doug mentioned, investment in research and development is a key element of our business and is among our top priorities. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the fourth fiscal quarter of 2011, we generated operating income of $2 million compared to an operating loss of $290,000 in the fourth fiscal quarter
last year. We are very proud of our rapid progress this past year and moving from large operating losses to the fourth-quarter operating profit margin of 13%. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The net loss for the fourth fiscal quarter of 2011 was $47.2 million compared to a net loss of $5 million in the fourth fiscal quarter last year. The net loss was primarily driven by non-cash, other
income and expense items, mainly the change in fair value of the derivative liabilities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because of these extreme fluctuations in our other
income and expenses, we believe it is best to measure our business progress based on our operating income discussed previously. We are constantly reviewing options to retire these derivatives that are creating the non-cash losses and we will update
you in coming quarters as we continue to improve our balance sheet. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Turning briefly to our full year fiscal 2011 results. For the year ended
June&nbsp;30, 2011, our net revenue increased 238% to $38.9 million from $11.5 million last year. Gross profit improved to $33 million in fiscal 2011 compared to $9.6 million for last year. Operating income increased to $3.7 million in fiscal 2011
compared to a loss of $7.3 million last year. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating profit margin increased to 9.5% in fiscal 2011 compared to a negative margin in
fiscal 2010. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On our balance sheet, we are pleased with the improvements we made in fiscal &#145;11. Our cash and cash equivalents increased
to $6.4 million due to strong revenue growth and operating profits generated by the business. We generated $4.7 million of cash flow from operations for fiscal year 2011 compared to a cash use from operations of $4.5 million in fiscal 2010. Also
during fiscal 2011, an aggregate face value of $5.6 million in debt was converted into shares of our common stock, eliminating all long-term derivative debt which was one of our goals for the year. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">I would now like to explain this debt conversion and its impact on our shares outstanding. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the end of the third quarter of fiscal 2011, our shares outstanding were 74&nbsp;million and at the
end of the fourth quarter 2011 we had approximately 99&nbsp;million shares outstanding. The increased share count is primarily due to our decision to elect to redeem all of our convertible debentures, which resulted in holders of our convertible
debentures voluntarily converting their debt into approximately 16&nbsp;million shares of our common stock. Additionally there are approximately 9&nbsp;million shares of common stock issued as a result of exercises of outstanding warrants and
options. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe the debt conversion was a prudent decision and while it did accelerate the increase in shares outstanding, there are a
number of positive benefits, including the elimination of all long-term and convertible debt, reduced quarterly interest expense, and improved transparency of our financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To reduce the impact of the additional shares and due to the improvements made to our balance sheet in fiscal 2011 and our outlook for strong cash flow in fiscal 2012, we recently announced a share
repurchase program that authorizes us to utilize up to $5 million to purchase common stock over the course of 12 months beginning October&nbsp;1, 2011. Any such repurchases will be made only out of free cash flow from continuing operations and on a
quarterly basis will not exceed 15% of free cash flow for such quarter. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We intend to implement this buyback program while maintaining
sufficient resources to continue to improve our balance sheet and invest in expansion opportunities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Now turning to our outlook. As Doug
mentioned we anticipate strong growth in fiscal 2012. In order to ensure we are positioned to maintain this growth, we will be making investments in our infrastructure and increasing our operating expenses while being mindful of improving our
operating margin and profit. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the full fiscal year ended June&nbsp;30, 2012 we expect to more than double our sales and end the year with
revenue in the range of $80 million to $90 million. We expect to generate operating income in the range of $8 million to $9.5 million, which translates into an operating profit margin in the range of 10% to 10.5%. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To reiterate Doug&#146;s comments, we are very pleased with our accomplishments in fiscal 2011 and we look forward to building on our position in
delivering another strong year in fiscal 2012. With that, I would like to turn the call back over to Doug for closing comments. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Doug Robinson - </B><B><I>LifeVantage
Corporation - President and CEO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thanks, Carrie. As you can see and hear, we are very excited about the opportunities for
LifeVantage in fiscal 2012 and in future years. We are confident in our ability to achieve our financial goals for fiscal 2012 but more than doubling our top line and improving our operating income by 100%. As we see the demand for our products
accelerating we&#146;re committed to making the steps to ensure we&#146;re able to meet the demand and maximize our potential, all the while being careful to grow in a responsible and profitable manner. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">I&#146;d like to open up the call for questions at this time. And as I mentioned at the top of the call both Carrie McQueen and David Brown are with me
and prepared to answer questions as well. Operator? </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>QUESTION AND ANSWER </B></FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Operator </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Operator Instructions). Steve Wymer from Bolt Capital. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Steve Wymer - </B><B><I>Bolt Capital - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Hi there, a question for you
with regard to your distributor base. I was wondering if you could give some numbers on how many total distributors you have and how that has progressed year over year and quarterly? </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B>Doug Robinson</B> <B><I>- LifeVantage Corporation - President and CEO </I></B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thanks Steve. I&#146;m going to ask David Brown to address that. Directly. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>David Brown - </B><B><I>LifeVantage Corporation - President of LifeVantage Network</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Yes, thanks, Steve. For competitive reasons, we don&#146;t give out the number of distributors but it is safe to say and I think we can all generally assume that, given the growth in revenues, that
corresponds to an increase in revenue &#151; I&#146;m sorry, an increase in distributors quarter over quarter as well. At some point we probably will disclose and make that a reporting metric that we will go over each quarter in our various reports
and earnings calls. But for now we prefer to keep that confidential. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Steve Wymer -</B> <B><I>Bolt Capital -
Analyst</I></B> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">And then another question. You gave &#151; in your 10-K, you gave some statistics out, 65% of the customers are preferred, 25%
independent distributors, 10% retail. What is &#151; what does a preferred customer need to do to become an independent distributor? Do they just need to sign somebody up or is there more &#151; what gets somebody from category one to category two?
</FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>David Brown - </B><B><I>LifeVantage Corporation - President of LifeVantage Network</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Yes, generally a preferred customer is someone that&#146;s been introduced to the product and to the Company and has probably had the opportunity to become a distributor. And then what happens often is
they are so pleased with the results on taking Protandim they find themselves talking to everyone about it anyway. And then they think, well, I might as well be making some money off of this if I&#146;m sharing the benefit. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">So then all they have to do is contact customer service and they then enter into our standard distributor agreement and can become a distributor. And
they can, then, in order to earn a commission there are various things they have to do in terms of continuing to autoship and things like that. But it&#146;s a very easy process for them. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Steve Wymer - </B><B><I>Bolt Capital - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">So it has to do with paperwork
essentially not through buying more product? Or does it entail buying more product when you go from preferred to independent distributor? </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>David Brown - </B><B><I>LifeVantage Corporation
- President of LifeVantage Network</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to earn the highest &#151; it all depends upon what level their current monthly
autoship is. But in order to qualify for the highest level of commissions it could involve a higher monthly autoship order as well. It just depends on where they currently are. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Doug Robinson - </B><B><I>LifeVantage Corporation - President and CEO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thanks
for your questions, Steve. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operator </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Flink from Next View
Capital. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Stewart Flink - </B><B><I>Next View Capital - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Guys, great quarter and
great year. Congratulations. (multiple speakers). Do you have any plans to go onto NASDAQ? And if so what are those plans? </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen - </B><B><I>LifeVantage
Corporation - CFO</I></B><B> </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Hi Stew, this is Carrie. We definitely have plans to move up to a national exchange. The sooner the
better. We have some work to do in our balance sheet. We are taking it very seriously. We&#146;ve discussed it internally. We don&#146;t have anything to announce at this time but that is definitely our chosen direction. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Stewart Flink - </B><B><I>Next View Capital - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Okay. And I had one other
question about your guidance for operating margins for 2012. I think I heard 11%. Is that correct? </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen - </B><B><I>LifeVantage
Corporation - CFO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">I think you rounded up from my 10.5% </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Stewart Flink - </B><B><I>Next View Capital - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Okay, sorry. (multiple
speakers). I am an optimist. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen - </B><B><I>LifeVantage Corporation - CFO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">That I gave 10% to 10.5%, yes. (multiple speakers). </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stewart Flink - </B><B><I>Next View Capital -
Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">And do you see those margins expanding as revenue grows or do you expect it to stay the same? </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen - </B><B><I>LifeVantage Corporation - CFO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are going to be
investing in our infrastructure and expenses this year to make sure we can continue this type of topline growth. We think a reasonable target for our Company in the future will be a 15% operating margin. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Stewart Flink - </B><B><I>Next View Capital - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Great. That&#146;s all I
had. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Doug Robinson - </B><B><I>LifeVantage Corporation - President and CEO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thanks
for your questions. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Stewart Flink - </B><B><I>Next View Capital - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sure. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Operator </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jim Galloway. Galloway Enterprises. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Jim Galloway - </B><B><I>Galloway Enterprises, Inc. - Analyst</I></B><B> </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Great year. Just a couple of questions. Number one, is the Primetime Live ABC video was great on
LifeVantage website. Are there any plans to return that to the site? </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Doug Robinson </B><B><I>- LifeVantage
Corporation - President and CEO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thanks, Jim, for the question. David, do you want to address that? </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>David Brown </B><B><I>- LifeVantage Corporation - President of LifeVantage Network</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Yes thanks Jim and we are actually in communication with ABC. Obviously they own the copyright to that and we don&#146;t know for sure whether we&#146;ll be able to obtain another license to put that on
the website. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also recognize that that information was first presented over six years ago and that we didn&#146;t even know that Protandim
was a Nrf2 activator at that time. The science has progressed so far. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">So what our focus is is that while people will obviously be able to
access that feature on YouTube and over the Internet, what we&#146;re really focusing on is to get new national exposure for Protandim and our products and the science behind it. And that&#146;s really the driving force behind retaining Donny Osmond
so that we can take advantage of his media access and frequent national appearances to tell the story about Protandim and update consumers who may have seen that ABC Primetime piece on the status of the science to date. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Jim Galloway </B><B><I>- Galloway Enterprises, Inc. - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Great. Another
question I have is you talked several times about research and development and how we&#146;ve got two of our members of the Scientific Advisory Board working full-time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We used to have some medical doctors on the Board. Are there any plans to add medical doctors or is there some concern about having medical doctors and working with the FDA and representation? Or can you
give me some more insight on what the plans are, the mission statement for the Scientific Advisory Board. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>David Brown </B><B><I>- LifeVantage Corporation
- President of LifeVantage Network</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sure, what we&#146;re really looking at having two types of Boards. One is a Scientific
Advisory Board headed by our Chief Scientific Officer Doctor McCord that really is engaged in R&amp;D, both primary research that the company is conducting and sponsoring as well as collaborating with those independent institutions and studies that
are going on as well. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to that, having a Medical or Health Advisory Board comprised of health professionals, medical doctors,
chiropractors, naturopaths, all types of health professionals to tell the story and be prepared to help us in answering questions and addressing that to distributors and consumers, you might be interested to know that unlike many companies in the
network marketing arena particularly, we have a number of distributors who are medical professionals, MDs in particular who despite who &#151; despite the stereotypes often associated with this industry &#151; are still so impressed with the science
behind the product that they feel compelled to not only talk to their patients about it but become distributors as well. So you can expect to see and hear more about that in the future. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Jim Galloway </B><B><I>- Galloway Enterprises, Inc. - Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Great,
that&#146;s all for me. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operator </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Operator Instructions).
Michael [Roller]. Please go ahead, sir. And he has dropped out of the queue. We will move next to we will move next to [Melanie Hillam]. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Melanie Hillam </B><B><I>Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Hello. My question is with regard to tools for distributors. Are there any plans to put together an online presentation rather than having people come to weekly meetings or to person-to-person meetings?
</FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>David Brown </B><B><I>- LifeVantage Corporation - President of LifeVantage Network</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Well, thanks for the question and we would be happy to talk about that more in detail off-line if you&#146;d like, either through customer service or e-mailing me directly at dbrown@LiveVantage.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">But what I can say is that while there will never be a substitute for person-to-person contact at being able to explain the benefits of the
product as well as the opportunity associated with becoming a distributor, that we do take advantage of technology and will continue to do so in order to get the story out and increase brand awareness of LifeVantage and Protandim in all of our
products as much as possible. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Melanie Hillam. Thank you and what was that e-mail address? Sorry. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>David Brown </B><B><I>- LifeVantage Corporation - President of LifeVantage Network</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dbrown@LifeVantage.com. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Melanie Hillam </B><B><I>Analyst</I></B><B>
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thank you. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operator </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">One final reminder. (Operator Instructions). Dan Wurtz. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dan Wurtz </B><B><I>Analyst</I></B><B>
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes, in reviewing the statement of operations there is two non-operating expenses that show up, your interest expense and the change in
fair value of derivative liabilities. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen </B><B><I>- LifeVantage Corporation - CFO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Yes. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dan Wurtz </B><B><I>Analyst</I></B><B> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">What is the ongoing plan to address those two items? </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen </B><B><I>- LifeVantage
Corporation - CFO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The numbers you are seeing in our other operating income and expense comes from the valuation on a quarterly
basis of the warrants that are outstanding because of some treatment within those warrants and some terms in conditions we are requiring to value those on a quarterly basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">It&#146;s largely driven by the stock price. It is a non-cash liability and as we change the liability on the balance sheet, the offsetting entry goes on to the income statement in a non-cash entry. As
those warrants reached their expiration term over the next few years those will naturally age off our </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
balance sheet. People will exercise those warrants, at which time they come off the balance sheet and there are some proactive things we may take to retire those warrants earlier than they might
otherwise naturally. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dan Wurtz </B><B><I>Analyst</I></B><B> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Are these expenses that the Company will actually incur at some point in time? </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen - </B><B><I>LifeVantage Corporation - CFO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">No, what happens is
the warrants which is an outstanding share of equity is assigned a value and that value is remeasured on a quarterly basis tied to our stock price. When the warrant is exercised, we satisfy that warrant by issuing a share of stock as opposed to any
cash amount. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">However, because some of the turns in those warrants trigger the surrogate derivative accounting, the SEC requires that we put a
financial number on our balance sheet for that liability. And I&#146;d like to reiterate these are all non-cash entries, both on the balance sheet and income statement. We do not expect to satisfy these in any type of cash. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Dan Wurtz </B><B><I>Analyst</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">And if the warrants are exercised will that be
additional stock that&#146;s issued by the Company? (multiple speakers) the increase in the shares greater than they are right now? </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Carrie McQueen - </B><B><I>LifeVantage
Corporation - CFO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes and all of this is in &#151; the schedule is in our 10-K in quite a bit of detail on this. But in short,
we ended the fiscal year with 99&nbsp;million shares outstanding. There are approximately 25&nbsp;million warrant shares outstanding and about 10&nbsp;million stock options outstanding. When those are exercised, we generally issue fewer numbers of
shares than that in a net exercise basis. But yes, those will be additional dilutions but not a cash satisfaction. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operator </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">And we have no further questions at this time. I would like to turn the conference back to our speakers for any additional or closing remarks. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Doug Robinson - </B><B><I>LifeVantage Corporation - President and CEO</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Again,
thank you for your time today and we look forward to seeing many of you over the next few months as we attend different investor events. Thanks for your time today. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operator </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">That does conclude today&#146;s presentation. Thank you for your participation. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>INAL</SMALL> T<SMALL>RANSCRIPT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sep 28, 2011 / 08:30PM GMT, LFVN.PK - Q4 2011 Lifevantage Corp Earnings Conference Call </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DISCLAIMER </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Thomson Reuters reserves the right to make changes to documents, content, or other information on this web site without obligation to notify any person of such changes. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the conference calls upon which Event Transcripts are based, companies may make projections or other forward-looking statements regarding a variety of
items. Such forward-looking statements are based upon current expectations and involve risks and uncertainties. Actual results may differ materially from those stated in any forward-looking statement based on a number of important factors and risks,
which are more specifically identified in the companies&#146; most recent SEC filings. Although the companies may indicate and believe that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove
inaccurate or incorrect and, therefore, there can be no assurance that the results contemplated in the forward-looking statements will be realized. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">THE INFORMATION CONTAINED IN EVENT TRANSCRIPTS IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY&#146;S CONFERENCE CALL AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION, THERE MAY BE
MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE CONFERENCE CALLS. IN NO WAY DOES THOMSON REUTERS OR THE APPLICABLE COMPANY OR THE APPLICABLE COMPANY ASSUME ANY RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS
MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY EVENT TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY&#146;S CONFERENCE CALL ITSELF AND THE APPLICABLE COMPANY&#146;S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR
OTHER DECISIONS. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All Rights Reserved. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">THOMSON REUTERS STREETEVENTS&nbsp;&nbsp;|&nbsp;&nbsp;<U>www.streetevents.com</U>&nbsp;&nbsp;|&nbsp;&nbsp;<U>Contact Us</U></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&copy; 2011 Thomson Reuters. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. &#145;Thomson Reuters&#146; and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right">


<IMG SRC="g238735pageformat.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g238735ex99_1pg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g238735ex99_1pg001.jpg
M_]C_X``02D9)1@`!`@$!+`$L``#_X07<17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````4````<@$R``(````4````AH=I``0````!````G````,@```$L````
M`0```2P````!061O8F4@4&AO=&]S:&]P(#<N,``R,#$Q.C`Y.C,P(#`T.C4S
M.C(Q``````.@`0`#`````?__``"@`@`$`````0```L:@`P`$`````0```#P`
M````````!@$#``,````!``8```$:``4````!```!%@$;``4````!```!'@$H
M``,````!``(```(!``0````!```!)@("``0````!```$K@````````!(````
M`0```$@````!_]C_X``02D9)1@`!`@$`2`!(``#_[0`,061O8F5?0TT``O_N
M``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43
M$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-
M$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#/_``!$(``L`@`,!(@`"$0$#$0'_W0`$``C_Q`$_```!
M!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$`
M`@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R
M!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5
MXF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7
MI[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q
M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S
MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_
MV@`,`P$``A$#$0`_`.3Z9ATYN2:+K74,%5UV]E8M/Z"M^4YGIFRCZ==+_P#"
M?36DWZH=2L97;192^JX5^FYQ>T[K/IU/9Z;]CL?W>H[=Z3_\`^VW]$L6OZ7Y
MW#OH\_1/_1_TG_!H[(VN_I'#/HS'TQ]+_P!$_P##KHI1F3<95X$<3FQ,:UC?
MU=(?5'J3R17=CV@#<XL=82*QZOJY+JS2+OL]/V=];W^G_/>E13ZMMBC_`,VK
MZ<K#IS\BK&KS++:3:W=9Z;J0UQ]9I%+/TGJ5;;/5]*OU-^0^I4:]NQG]*_GF
M?0F.?S/^[/\`H?Y:6)'VBK^E<O\`YF?4^C_@?_1W_!H<.3]\?XJ>*'[OXN@[
MZI=0_3$74L^SM)N;<XU%A:*W65O+FNHW5.R,>I[_`%O2]6W^<]+U+%-WU3NH
M%IS<NJKT:K;;!5^FVFDXC'56NW4L9;ZF>QEC/YROT_H6^K4LFJ(K_I'T'_0G
MP=_-?\%_ID>O;(_IO\W^9,_S?_GG_P!UT.'+^^/\57%C_=_%ON^IG5ZP/6MQ
M*GRYIK-I+P6$5O\`976]WMN>RASF?S=EE?J>Q4\OH=N+2[(?<Q]+/1%A8'%[
M#D45YM/JT_F4O];[-7=O_26^HJS-OH'^D?SGYL[.&\_\/_Y@FNC[.S^?Y;_.
M3Z?T!]#_`-%?\"B(Y.LP?*-*XH=(_BUTDDE(QJ3L;O>UG&YP;//)VID[>1SS
MVY^22G5N^KM].7U+$.30Y_2V[[+&O_1N$[#7ZO\`@+V_0]*W_#_H%4R^G68N
M+B93K&.9FUBQC)BQO]:IWN=7_P`.W]'O_1JH/H'GD?#D_3_E?]_3NY'/T1S_
M``_D?N*,1R`BY@BQ8X:TX.&O_#/UG_,7DPUJ-=M5DDDE(L?_V?_M"IA0:&]T
M;W-H;W`@,RXP`#A"24T$)0``````$``````````````````````X0DE-`^T`
M`````!`!+`````$``0$L`````0`!.$))300F```````.`````````````#^`
M```X0DE-!`T```````0```!X.$))3009```````$````'CA"24T#\P``````
M"0```````````0`X0DE-!`H```````$``#A"24TG$```````"@`!````````
M``$X0DE-`_4``````$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8`
M``````$`,@````$`6@````8```````$`-0````$`+0````8```````$X0DE-
M`_@``````'```/____________________________\#Z`````#_________
M____________________`^@`````_____________________________P/H
M`````/____________________________\#Z```.$))300````````"``$X
M0DE-!`(```````0`````.$))300(```````0`````0```D````)``````#A"
M24T$'@``````!``````X0DE-!!H``````TL````&```````````````\```"
MQ@````L`90!X`#D`.0!?`#$`<`!G`#``,``Q`````0``````````````````
M```````!``````````````+&````/``````````````````````!````````
M`````````````````!`````!````````;G5L;`````(````&8F]U;F1S3V)J
M8P````$```````!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO
M;F<``````````$)T;VUL;VYG````/`````!29VAT;&]N9P```L8````&<VQI
M8V5S5FQ,<P````%/8FIC`````0``````!7-L:6-E````$@````=S;&EC94E$
M;&]N9P`````````'9W)O=7!)1&QO;F<`````````!F]R:6=I;F5N=6T````,
M15-L:6-E3W)I9VEN````#6%U=&]'96YE<F%T960`````5'EP965N=6T````*
M15-L:6-E5'EP90````!);6<@````!F)O=6YD<T]B:F,````!````````4F-T
M,0````0`````5&]P(&QO;F<``````````$QE9G1L;VYG``````````!"=&]M
M;&]N9P```#P`````4F=H=&QO;F<```+&`````W5R;%1%6%0````!````````
M;G5L;%1%6%0````!````````37-G951%6%0````!```````&86QT5&%G5$58
M5`````$```````YC96QL5&5X=$ES2%1-3&)O;VP!````"&-E;&Q497AT5$58
M5`````$```````EH;W)Z06QI9VYE;G5M````#T53;&EC94AO<GI!;&EG;@``
M``=D969A=6QT````"79E<G1!;&EG;F5N=6T````/15-L:6-E5F5R=$%L:6=N
M````!V1E9F%U;'0````+8F=#;VQO<E1Y<&5E;G5M````$453;&EC94)'0V]L
M;W)4>7!E`````$YO;F4````)=&]P3W5T<V5T;&]N9P`````````*;&5F=$]U
M='-E=&QO;F<`````````#&)O='1O;4]U='-E=&QO;F<`````````"W)I9VAT
M3W5T<V5T;&]N9P``````.$))3001```````!`0`X0DE-!!0```````0````"
M.$))300,``````3*`````0```(`````+```!@```$(````2N`!@``?_8_^``
M$$I&248``0(!`$@`2```_^T`#$%D;V)E7T--``+_[@`.061O8F4`9(`````!
M_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.
M%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_
MP``1"``+`(`#`2(``A$!`Q$!_]T`!``(_\0!/P```04!`0$!`0$`````````
M`P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$
M`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T
M<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2D
MA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$
M`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#
M4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34
MY/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#D
M^F8=.;DFBZUU#!5==O96+3^@K?E.9Z9LH^G72_\`PGTUI-^J'4K&5VT64OJN
M%?IN<7M.ZSZ=3V>F_8[']WJ.W>D__`/MM_1+%K^E^=P[Z//T3_T?])_P:.R-
MKOZ1PSZ,Q],?2_\`1/\`PZZ*49DW&5>!'$YL3&M8W]72'U1ZD\D5W8]H`W.+
M'6$BL>KZN2ZLTB[[/3]G?6]_I_SWI44^K;8H_P#-J^G*PZ<_(JQJ\RRVDVMW
M6>FZD-<?6:12S])ZE6VSU?2K]3?D/J5&O;L9_2OYYGT)CG\S_NS_`*'^6EB1
M]HJ_I7+_`.9GU/H_X'_T=_P:'#D_?'^*GBA^[^+H.^J74/TQ%U+/L[2;FW.-
M186BMUE;RYKJ-U3LC'J>_P!;TO5M_G/2]2Q3=]4[J!:<W+JJ]&JVVP5?IMII
M.(QU5KMU+&6^IGL98S^<K]/Z%OJU+)JB*_Z1]!_T)\'?S7_!?Z9'KVR/Z;_-
M_F3/\W_YY_\`==#AR_OC_%5Q8_W?Q;[OJ9U>L#UK<2I\N::S:2\%A%;_`&5U
MO=[;GLH<YG\W997ZGL5/+Z';BTNR'W,?2ST186!Q>PY%%>;3ZM/YE+_6^S5W
M;_TEOJ*LS;Z!_I'\Y^;.SAO/_#_^8)KH^SL_G^6_SD^G]`?0_P#17_`HB.3K
M,'RC2N*'2/XM=)))2,:D[&[WM9QN<&SSR=J9.WD<\]N?DDIU;OJ[?3E]2Q#D
MT.?TMN^RQK_T;A.PU^K_`("]OT/2M_P_Z!5,OIUF+BXF4ZQCF9M8L8R8L;_6
MJ=[G5_\`#M_1[_T:J#Z!YY'PY/T_Y7_?T[N1S]$<_P`/Y'[BC$<@(N8(L6.&
MM.#AK_PS]9_S%Y,-:C7;59)))2+'_]DX0DE-!"$``````%4````!`0````\`
M00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@
M`%``:`!O`'0`;P!S`&@`;P!P`"``-P`N`#`````!`#A"24T$!@``````!P`(
M`````0$`_^$22&AT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\`/#]X<&%C
M:V5T(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G
M/SX*/#]A9&]B92UX87`M9FEL=&5R<R!E<V,](D-2(C\^"CQX.GAA<&UE=&$@
M>&UL;G,Z>#TG861O8F4Z;G,Z;65T82\G('@Z>&%P=&L])UA-4"!T;V]L:VET
M(#(N."XR+3,S+"!F<F%M97=O<FL@,2XU)SX*/')D9CI21$8@>&UL;G,Z<F1F
M/2=H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D9BUS>6YT87@M;G,C
M)R!X;6QN<SII6#TG:'1T<#HO+VYS+F%D;V)E+F-O;2]I6"\Q+C`O)SX*"B`\
M<F1F.D1E<V-R:7!T:6]N(&%B;W5T/2=U=6ED.F8T,6,W930X+65A9&,M,3%E
M,"TX93!E+6,W-&%C830U.3EC-R<*("!X;6QN<SIX87!-33TG:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87`O,2XP+VUM+R<^"B`@/'AA<$U-.D1O8W5M96YT240^
M861O8F4Z9&]C:60Z<&AO=&]S:&]P.F8T,6,W930V+65A9&,M,3%E,"TX93!E
M+6,W-&%C830U.3EC-SPO>&%P34TZ1&]C=6UE;G1)1#X*(#PO<F1F.D1E<V-R
M:7!T:6]N/@H*/"]R9&8Z4D1&/@H\+W@Z>&%P;65T83X*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E
M;F0])W<G/S[_[@`.061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#
M`P,#`0$!`0$!`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P/_P``1"``\`L8#`1$``A$!`Q$!_]T`
M!`!9_\0!H@````8"`P$`````````````!P@&!00)`PH"`0`+`0``!@,!`0$`
M```````````&!00#!P((`0D`"@L0``(!`P0!`P,"`P,#`@8)=0$"`P01!1(&
M(0<3(@`(,11!,B,5"5%"%F$D,Q=2<8$88I$E0Z&Q\"8T<@H9P=$U)^%3-H+Q
MDJ)$5'-%1C='8RA55E<:LL+2XO)D@W23A&6CL\/3XRDX9O-U*CDZ2$E*6%E:
M9VAI:G9W>'EZA8:'B(F*E)66EYB9FJ2EIJ>HJ:JTM;:WN+FZQ,7&Q\C)RM35
MUM?8V=KDY>;GZ.GJ]/7V]_CY^A$``@$#`@0$`P4$!`0&!@5M`0(#$00A$@4Q
M!@`B$T%1!S)A%'$(0H$CD152H6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U
M&50V160G"G.#DT9TPM+B\E5E=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U
M*$=79CAVAI:FML;6YO9G=X>7I[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FY
MR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H`#`,!``(1`Q$`/P#5[]]X>N>'7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=?_]#5[]]X>N>'7O?NO=>]^Z]U[W>-&E?PT'?2OIPZV`34@&G7
M=B/Z?[<?\5]M%E"ZR>W53\^M*"Q"J,GKC<?U]N%&`J>'5BCJ:%37KL#5].?=
M?P:_P]5../7K@^]:AZ]7:-E57([3PZ][]4=4Z][]4=>Z][]4=>Z][]4=>Z][
M]4=>Z][]4=>Z][]4=>Z][]4=>Z][]4=>Z][]4=>Z][]4=>ZZ)`][\F-<`=;"
MDUIUZX]M)-'(K.K=HXUQ_AZND;R&BC/7@;_2_P#MB?=I76'P?$J!(1IQQKUM
MH73XJ?M'7KV^MQ_K@^W)1X$GA2X>G5`I-:>77;>D`DCGZ6(/^/X]M12)-*T$
M9/B#U%!^TXZT@+G2HSU[W>H]>M=>]^J.O=>]^J.O=>]^J.O==7]T:5%(4G)Z
M]UW?V^L;L-0&.O==7']?>F1E%2,4ZW0\.N04L+@7'MM65F*AAJ"U_+JI(4T)
MSUU]/K[N5*Q),:>&QH#7_)UOKWNM1U[KWOU1U[KWOU1U[KWOU1U[KWOU1U[K
MWNDDL<2ZG-!4#\SPZ]UX\&QX]WE(A4-*P`/[?V=.)$[HSJ.T=>]U5U8!E..F
M^NP">![M4>O7B:<>O$$?7WY65S16%>M5!ZXW'T]Z+`5X]7*L,D==^]"12:"M
M?F".J]>]WZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7_]'5[]]X>N>'7O?NO=>]^Z]T=7X5_`3Y`?/O=6ZMF?'[
M'X.NS>S\7'F,P<]5S45'!1RD*A$L2.?([L`HMR2![C#W,]U>6?:ZTL+OF".=
MIK@L(A'D]M-5<CU'0MY7Y4W/F666.PX(`6S3!K\C_">K&T_X39_S,CJ+;<ZW
MLIOI.X:@,ZCFR^FUS[BB+[V_M8MLL,FWWQ<FM:#!_P!ZZ'MQ[.;]'%KCD#-2
MM`PK7_>>/11?D]_*3^5WP]W!T9M_O+^X>WZCY#=EXGJK8%1396LJZ2'<>7JJ
M.EAJ<UXH))X,7`]<FMT1F!OQ['G*?OYR-SMM^];OM-A>^'MD322*5R0`3Z^=
M*#HFWCVYW7:VVR*\N5#3,!\0-*T\](X5SUQ_F8?RR>Q?Y9&Z.F-E]D;]VSV!
MN#MG:&YMT/4[1@KHL)B&VUFJ##S44+Y*DHZ^<SFO60%X^`+?U]J_9CW9V_WA
M;F&[VNRD@M;1PNB2A:I!-<$C%"./$=(N<^1I.4EMHYKA9'D&JHK2@)'GY]5E
M$!78`W%^";@D?ZUOK[E:)M<#25X2Z?Y]`$DO"H(RO7O;O377O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>XL;_P"P]L3J"%8O
M15-3\^K(I9T4>9Z>]N;=SFZLSAML[9PN1W%N;<F3H<-M[!XN'[BOR^6R%3'2
M4>/I(007GJ9YE4?15)NQ"W/NN[7VSV%@=PW6X6#;U6I)-!0<3^7'I7%:27MZ
MMI:@ER0*?/K86ZP_X3#?S$=_;+I=V9K<G2W5>4R-(E5#LC?&4W&^Y*)WB644
MF7_@.*RN.I:A2VA@LS`-_A[Q6WK[W/MA:7TEA%87]Y!`U`Z`!:`X*U8$B@Q0
M=2[;^S.^W<4<ERR(:#!8`G'IIP?MKU6E\UOY8?S`^`Z4.4^0.PZ6CV7E<O%@
ML-V-@<I1UFT\SEIK%:&@26J3-&;2P-GIE`#"YY]S![8^Z_MW[F3S2[%=7)W(
M1:GBE!!C7R/GQSY^702Y@]O=\Y=`DN8A].S:5((:I&?(#R^719]X?&WOKK[K
MO;?;^^>IMY;2ZLW?6G';7WQG:".@Q&?K/$DPAQB5$RU\Q:*16U&()I-[^Q)M
M?/'+>Z[INVP6NY1W.Z6S=R1FK**TS_EZ(+CE_=K2P2_NK5H[9C@L*?ZORZ!0
MBQ(_H2/8M'`8Z(?SZZ][Z]U[W[KW7O?NO==>W$@\0&3TQU[IVP.!S6Z<YB=M
M[9Q.0SV>S]9%CL)AL73O6Y++9"6X6AH:2`/--5.P.E0.0#[2W5]#9V\[W<ZQ
M6RJ2SDT"@<22>%.E4%K-<ND<"EIB:`>=3P_+^?0A=K]%]M=";CH-I]V]?;CZ
MSW+D]N8W=V/V_N6&G@RU1MO,>;^%Y84L%1.T-/7_`&S^,2:')0@J+>P_R_SC
MLW,.U_5<OWR7UG%.R,R$GX>(_+I9N^V;EM4\-MN%N8YFI@BF#U9=\=/Y&OSO
M^4O2G7W?O5&%V95]?=F8:3.[8J,EEYZ2MDH(ZVLH+U$6C2KFHHG''''N*N9_
MO->V?*^^[CLE]8W+74/8Q05'D?49ST.=H]KMZWBQ2^MD4QG'<P7/R[3CJ3\A
MOY%WSI^+W2?87?W;6.V-CNO^L\)%G=RU-!F9ZFKCHY\E18N-((6CO)*U57QB
MWTL?K[0\G_>0]O>;=\LN6[6VNUO+B73#J';JH34Y.*`]-;G[8\P;9:W-W+;`
M0Q+J)U`_\^BO5./O(GJ->O>_=>Z][]U[KWOW7NO>_=>ZZ/(_WK_$_0#_`&/O
M34TN2M2%)`^8X?SZ<BU:QI6IZ'?J3XQ?(3OJ@SN2Z7Z9WWV5C=M0U,^X,KMK
M&Q2XO"PT5&V0K'KZ^JGIJ5/MJ)&E90Y?0+V^GL(<P<]<E<O':H.:MU2WWF=P
MJ1DT+$FBXXY-!T>6'+6^;I;27UG:,;50:D`TQGRZ`Z>GJ*2HJ*2KB:"JI9Y:
M>HA>VJ.6)RCH2I*G2P^H)!]C$NLE'044CHBD0QL5(R.L8#-PH)-OQ[9E?0JG
M^D!U2JC+<.LD$<\TJP14U7532LD=-3T5-/65574.VE:6DI:9):BHJ"2/2BD\
MCWO<!M5I!XUW=Z,5X]++>QDN^Z$8K3[/F?EUFFQ]?"TJS8K-4CPL14)58FO@
M-)8V85ADIE6F=7X(<J0>#SQ[;@FLY%0VF[1M4"F1PIT^^W[E;J7D@.A?/R/V
M>O433:Q!!O\`T_WUO:MUN0!XLRLGE3I`\ID`4I0CKOWOIKKWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z&'<'Q][NVKT]L7Y![AZQ
MW5C.D>S:K,46Q.SI*%9]J;@J]OY*?#YF&.NI99VQ[4.4II(":M8`\BD(6]AZ
MUYKY;O>8-QY5MMXA?F.T5&FMZD2(KJ&4T(`:JD'M)H#FG1U+R]O$.V6^\26+
MC;Y695>F"RG20/4U!%/V=`][$/1+U[W[KW0O=,=`]T?(K<F1V=T;USN'LW=.
M)P60W-D<#MJ.EFR-/@<5!+59')>&JJ:;S14M/`[%8R\C:;*I-A[#_,7-7+O*
M5I!?<R[M%9V<LJQJ\E:%V-%7`.22../GT<;/L.[;]++#M5F\TB*6(7)`'_%C
MH+,A05^)KZS%9:@KL5E<?,]-7XS*4=3C\C0U"$AX:NAK(H:JFE4C]+H#[.X9
MH;B*.>WE62!Q564AE(]014'HMGMY[65X;B(I*IH0>((X@_,>8\NHGMWIGKB[
MK&C2.P5$4L['Z*JB[$_X`#WZE<#CU959V5%%6)H.AV[G^,GR"^.L>TI^\.H]
MY=:TF_,#0[GV=D-P8]/X7N#`Y.GBJZ#(4&5H9JS'$55+.DBQ/*LVE@2@]ACE
MWG3E3FQK^/ES?K>[DM96CE5"=2.I(92K`'!!%0"/GT=[IRUO>S16\^X[?)'#
M*H96(P0144Z`OV)^B+KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__TM7OWWAZYX=>]^Z]U[W[
MKW1F?C-\QOD3\.\_G=S?'?L&HZ^S>Y:`4.:K::E2I>LI(0?'$0\D>D+?_'V!
M^=N0^5^>+6&/F7;1<);AC'4TTDTKT(=CYBW38O%?;KEXRU`=-!Z_(^I_;UN_
MY[YI?)&G_P"$^^Q?EQ#V#4)\@<KL;:&6KM_&E4SU&1R&ZZB@JJUJ;RA;R4JA
M2-7X]X"6?(W*\GWF+[DF3;0>6DG91#7``C#`5^WK)_<^8-V'MXN[K=$7X'Q'
M)I7SX5-.M/\`J/G)\H/F7\E/B*_R-[/R'81V7WWTZ=MK54RT\>/:O['VTM5+
M&%ED'DE60B_]#[S/DY%Y8]NN2?<*+E#;5M([FSF\0`UU4C;J`HN9]VYCWO9X
M=TNFEC6<``D8!/#`'6Z1_.?_`)9W4WS8[3Z%[7[Y^4VW_C1U=U/L[=NT9I,A
M#BVRFZ\]NS<>)R=+3TE3DLAC_P"'TT,6/=7E0N=;J+<^\#?8OW;YB]M(M[AY
M<Y;;<;NY*LR@&BJJ%:D@'.:@4SUD)SQRO8;Y);2[A?)!;HND:O,EB>'SKZ>7
M6L-_-K_DU83^7[UMUW\A.INY:GN#IKL'*XW`25.1Q])25&'R&8CUX"KH*ZEK
M:X9RBS@20AR8]&CB]_>7/LA[\W/N5>;IRUOFRK8[[`BL%6N60D.34`ACC%/+
MJ&N=_;R+EW;H;W;Y1+;O4U'R%<?*G2Q_E\_R&LM\I?CI%\O/D;WK#\9>BJZA
MK<[@:FLPM#D*[-[5H"PEW/D*K(U^,BV_AW\,GCEU2&1HV`'%_9?[G_>77DOF
M23D_EO8EW'=T(5^/:Q%=.`QU#T`\QTJY:]JFW';(-SW*Y6*!Q4$D\/EY$'YC
MID^?7\D&E^/'QOHOF1\3._Z#Y6_'=+3[DRN+I*"GJL-B7J3CXLSB:W&5N43/
M4"9&T<QU1F&Y)%@+JO:C[Q#<X<S?U/YOV/\`=N]N*QC-&\Z=P4U/EC/3?-?M
MO;[7MK;OM5TLUFN&(/PGYTQ3\NEY\`_Y`,7SH^'--\J,5\H4V?7;EFW5B]N[
M.J]F4+87%9/:.=_A&0J,YN:7*K*M#XJ>>3_,6X3^MP2>X'WE[KDCGI^6&Y>,
MUO#(NHCXF5@=.@4JQ)IQ_P!CK7*GMK#S'L3[LTZQZ"PI4U)6E0U30#/E0^OK
MT:/=?_"8[:F]=A;?W5\5?FIMCM*?%;KH]K=DY+.8[%8S:U!2TDHCW=E:#)X[
M)9:-,S@49&2@8(LI:QD7V&]O^]WN>V[M<6'-?)#0>-&3`@!,A/X1I(%:_*O1
M]?>SUF]A%<[7N".0W>2U`!YFM12GSSZ=,^__`/A-SU*WQ\[4[$Z$^;M'W%V)
MTSMS<N;W5C*#;N'&W,ADMJ8>JS65VZ]3CLW7G#US4],4A&@EB03:_MO9OO3\
MU+S/M&R\U<E&SLKV541B&##6X56HRKC(K3\NMWWM)MC[3/=;7N222Q*2:&O`
M$GYX\J\?/JJ7^5+_`"G.P_YGF\]\TE)O`]2];=8QXZ'>>]SBX]PUBY[(>*:/
M:^,Q4\M)%49'[-S*7:5-"*?<Z^\WO5MGM%M%@5MA>;S<GL2OE2M3_1KBHJ?E
MT".1>0CS1>7)N'*[?$3J;AYT%,\32M/3JQWO3^2/_+XVWM'MJFZM_F:[6J>V
M>B=N9K.;\V1DZ?;U?7BIP"A:W'9*@7/_`'>#F:H(BTHDI1V%Q[A?E3[QON5N
M>Y[:=U]N'7:KJ10&17(52>(J@!^9_9T+=V]NN5K2.]DMM\1I8HR?#-`:C[*$
MG\^JP_Y9O\J/O+^97OW/4&S:ZGV!T]LFJ%/O?MO*TXJXJ.H>HE@BQ&VL7)HB
MW#F@L6N:(RPB%'4EB#[FOWA]YMF]K=OLYY%\7=)@3'`,L00"NH>0!!!)\Z`9
M(Z!W*'M]=<T2O*C:;1"*D\"..*4X^75JG9'_``G8ZHWCUCVAN'X0?-O;_P`B
M.T>F(,A%O'K1:#"J*S+XB"::OPLF0QN8R=1A,XYIV2GIC"5EG(C++>_N#-H^
M]9OL>YV,/.O*/[OVNYH$E`;S(H>Y5Q0BM.AM?^U&V3V5S+LVX)+<P@ZE!X4R
M?3.",U^6>JFOY6O\NF#^8C\G-V?'/=_963Z/R.R-E9?=6:=-NPYW*RY7!YZ#
M;^3VF:6JKJ!:.OI*R5O*^HF/QL`#;W/7O=[G#VOY'V7FS:8UO4NRHXX&H5R0
M#T!^3>2EYBW6>PEE"A*UK7\-.`^=1QKU>AU]_P`)=^M:O<VY>O>R?FS24'9Q
MFSF2VGL+:>$Q&5R]'LJFJ?%A=R9R&7,45=)/5PLKU$+1:(0P`=[W]XYWWWP=
M^BM;3=-NY&63:?T5DD>H4.0=84@&H)R#\NI-M/9[9S=W,,FXH[@84'(]*C^6
M/V=:UOSK^(NZ/@S\G.POC=NC.P;IEV=5QS83=$-.E&^X]N5:J^-S-10(SKCY
M*HZT,09[&,\^\K_;KG*#W&Y,L.;Q;B.W=F5X_1QY?8.H3YIV&3ES>+RR([4;
MM/J#PIT=7^0I3=45G\T/X_P]J&B6&.+=E1L9<I4)!C'WI%MVODI%J$E'ADFT
MA?!J(_>TVY]QI]Y9]X;VNN'VN%B`36G$)^+^70D]K8;67?HWO::2XK7ACX<_
M;7K94_G>].?SE<UV[M[MWX0[Z[#JNC]L;>I8H^M^D=P5.)["7<4;0RY6IRNW
M:14&ZJ&JE1W21YD\<1\=B#[Q,]B][]F1L5YM7N%:I'O4S@AI#0:?(*:>7GPI
MU-7N!8\WW%S%+L<A^G5:4&?F20,_9CUZU;.\/D[\L/GKW[\=OC3_`#!.UZCJ
MC!;#WQ@MB9C-[FV7'M23K&GRE5$,GO3?F+>K>#.9B!J&,/4R2*06O[S+V?E'
MDGD+E+FGG+VWA^HW)[9I"J-JUKIPB@F@X8R!7]O413;]N^X7NW;/OTYBMH'X
MG\1J`1P!X-7AP!ZW`_YQGQ*^-'<GPK^/6UNW_EI@^@=D=+8C);@V-N:?%XS)
M)VZ^*V'10G"X7'562H4:KK*.C26+PM*X>=;+;GW@][*\^<R<N^XNY;IMO+YO
M-QOYA%(N?TA)(=3$T-*5_EU-G/>R;5N'*EK%/N8BMXEUIY:B`"H]<^6/MIUJ
M[?RNOY-='_,NZK[^[%VQWU-LW(=0;VJMD;7VM-MBDGCWA/4XK^+X+-Y;+RY!
M)<'CYJ:IA614BF`8-<^\P_>CWVN_9[>N6-MN-G6YM+N!7D>M""90&TXR0*KQ
M`ZA3DWV]BYJCW&47"QQQ4H36IJ#Y<*#S\^%.GGY8_P`F&FZ;[$^+/QI^/W<L
M'R-^4O>TF4BWIMK%Q45!LW846#J:.DW%D*_-4%7D/L,5AJR>2))Y(E>;Q7**
M&'M/R3[_`%SNUCSIS5S3LRV'*-BP6%WJK.9-3(-)'Q`*.%?B`X]*MV]O-M@G
MVC:]NOA-N$H?4%HV5-`/LJ?/[<\>C]T?_"<'XTX3,;<Z![$_F)8';WR_WCMN
M+/X?K*#`8"2?6\)E\.+PLV>IZW-8S4"HJ#'&\@%PI]Q5+]ZWG&47&\V'(YDY
M1CE(\>C?"#^(A2M?EJ/SZ$*>TFRUAM)MX5=Q*U,=<DD5I7C^P]:^';'P3[[Z
MH^9U=\(:S;@S/;O]^J+96UXZ)Y?X1NFER\U'%C=V4E68%9=N"*N66HG\=H-$
MBD'1SECLGN7R[O?MP?<LN(=KB@+2*>(8`U!'J"*=1/?\G[G:;W^X`G^,&4+J
M\A4XS\P"?3!SUL'T'_";OXXX3*[2Z'[+_F'X+;GRZWOMYL[A.LJ7`8*:>6HC
MI6EJJ+%XF;.05F:QM%6HT35/C1VC4N$OQ[Q:'WM>;1'<[EMW(?C<JPR'5.=0
M.FO$T4J"!P!;[:=2^/:/8D:*QN=V"[HZ`A!YX]>.3Z'HI_\`+,^`==\?/YU.
MQ.B_DEO[#]7[S^/NXH.R.MEEIX)Z3O\`R*QU$.V=N[7K)GIU\N=QE;+6NJ!F
M@%,54.2/8O\`=OW-M>9/8-^:>6;=YEW53#*,CP$85=CQIIII_/HIY2Y.M]LY
MN6UOKH%XG!53FI0@@<?Q$4''H[/_``I>^,_QYG[.W-\JL]\I<=BN^Z38O4G7
MV#^+='A\;6;BRF&;*YZ.AW=45IR<>3@Q*O733R/]LT21QGU7L#&WW2.<N9+9
M[?E6VY>)V6=YI)+G-`R@$+6E*^7'_+T(?=;8;&\F?<IMQ07$:)IC\Q4&I]/(
M>OY>9Y>A]V_)K9O_``FUZ'SWQ+HMV9+OV@ZXP";0H=B8TYG<K)-VOF8LJ*.@
M$L!F5<492Y#>E+GFUO8"W7;.69OO,[[MW-3(W+IO7#:S13^BK<?],>C^"7<4
M]N;.;9*B\+$5'&FHBO`^5/(_9UK@]R?(;^:?VE5[#^-7\PG?7>O273'R!W/@
M-FY+(=@;'--%619#-T5+#44F-GRB)E(:7*>+6I9`MK^\J^7^6?:3:_WYS5R!
MMT%QNNWVTDB+&^KN4\#2OEU%.X7?-T]Q8[9NEVP2=P*&H!6N:U53P%<=(O\`
MFV_RKZG^63V1TWLO$=B9;N#;?;^W\AD,5NVMP-/MV2+,8G)8S&5N-DHZ"MR4
M"AY<I&\=I3J3V9>R_O(WN=L._7M_:);[K93=T:FO803JR!@4H<=%/.?(W]6-
MRM($DUP3+VGU/G3_`%?/HQOSB_D=XSX3?"G8/R6W)\@-R;H[B["K.N]O83H>
MDZ^Q\`R.Z-[3)Y\7BLQ#F9*VJDPT$Z,W^3@RL;$`$$A'D7[PFX\X^Y6X<N+M
M,2<K69E:2<$U"1\&;%,D'SZ$/,7MQM^Q<O[=?/<UW&9E&CR[A4Y%3CM'#))I
MT9SK[_A/+T?L?K7J7*_-[YR;<^/_`&_WE2XI-E];)3X5X(<UF(89J/"8^OR.
M4QE1N'*VJHUDB\**LI*!C:Y"W,7WJ=ZNMXW*'D3DPWFS64K!YJ-W`?)5(TTR
M#6M/*G1Q9>TNTI9VB[GNPAW"=`54T^T\?.GV</7JK[^9/_*B[+_EP]Q]8["W
M3O.'?_6W;V4HJ#:?;-#A4HA#+5;CQ^`J<9F<''+)3X[,4*U_GCB$\GW$,;-J
M6Q`F'VN][MO]U>5]_P!RM+,6^^;<I9XOXJ`G'RJ*5Z!G-OMU-R_N%C$C5LYN
M#5-!0$DD_,#A7SQCJXS<_P#PF!V1L:;9VZ-Z_./#;8Z<?`OD=Z[[W!MO$8:O
MGS=2U*,1B-OXNJS"TIH*D2OKJ/N`X"@A"?I!47WMM\N[?=-NL^2S+O"RTCTU
M/:#DM08_S]#63V<L+6.VN+S>(TA=16M<$YQZ_G7_`"]5\?S9OY+M!_+UZKZ^
M[]ZM[EJ.[.I=\Y=<'6U%?BZ3%56$JYZ>*7#Y"AJ*.MKX\M0YBHE\:G4H33?F
M_N4_97WZO?<S=KOE;>-B2SWVW770$]ZH:MQ`-:<13H.<[^WJ<L6EIN6VW0>W
M;!;_`$P\_*E,@];-'\B;HOJG9?\`*XWCCMK=VXC=E)W#C=Y9WL;,45'20CJ;
M+YK93X')8G+*M2WW%1@L3"M<YE,=T-OIS[Q#^\=S3N^Z^\ZR7FUF,;?)&L0.
M/$"-J%/7420/LZF#VSL8%Y-H+I6656U>BU%"/\OV4^?6FY\G_A)UKM?YA]<_
M%3X??(FC^7N:[*J<+CCN[&XG'8G%4FZ-PN)H<125>,R.6I<A_#<:LTU19QH,
M6D\WMG+[=^Y&\;S[<[[SMS9LPV^&Q!*J2>]4&3D`BO\`/J`>8N6+&+F%=NVR
M\\=I'R5R`6/#]II7R\J]7@;Q_P"$\/PG^..VMFXSY:?S&<9U?V9OND9,2F7H
M<%MS%566TQ>>DV_2U><C;,04$L@4N1'Y+W('O'M?O7<Z\Q3SR<K<@+<[;&Q`
M9=1)IYMI0@?D3U)<GM-R_9V\7[PW-(IV48-*`GT.2?\`5GJEGM#K3K?^6I_,
M#PVW<'W?1]U[,ZU<9.J[%P&S,;N&JI?XQ30G[?%[>CRWV,>Z*>E*/%6QU!:C
MD*RJ&(`]S_LVX[U[O>WD\T^UOMN_C*AJCAY4(R">/RZC2[L;#EG?3:0W<<]F
M2*D'!&:G43BF,>?0K[X_F"?%K*],=T=4[>Z,W9'E>V9\E)#O;>55/N#=>*,]
M?+E8JQ<S5)'///E,G:>4'3]NDAB!8+<D%E[8\Y[;OVR[I-OO^Z^%%\6)#V,<
M5J/L_GT<[CS%M%QM-W''$/'R%-<T^WJF%!HCCC/+JBAF_J0`"?\`8GWDHW@F
M*'P%HE/Y]1*Y#:I/5C^SKG[UTUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=?1!_DP;%V#VG_)A^-?6G:FR=N=C=<[QINYJ'=&S=
MU8Z#)XC+4R=P;G>%V@J%=(JRDD/D@F`U12`,MB`??%S[X//W,OM[]Y6;>^6M
MQDM[J.VA;L8J:^#$*@C@VG%?,5!%#UEUR.L$O(VT075NDMK)+<!T85#`3DC\
MP<@^1ZHU_FC?\)_=W]+1;D[^^$<&:[,Z<A2;+;IZBEDDR?8?6T:WDJY\/=34
M[IVY$FJ1Y&\+4R*`%8'WEQ]WC[X_+ON%;6FP<ZW$=IS`**)C14<\`)!^`\`K
M9UG..H]YQ]K!HFW7E==4()9X?QH//33XE!J105`-*F@'6L2RNCO'(DD4D;O'
M+%*CQ2Q21L4DCDC<*\<B.I!!`((]YU`A@&4@J>!'`]02Z,C%6%&'5['_``GQ
MR%=B/FAO+*XRJEH<EC>C=^UU#60-HFIJNEPV5GIYHV'T:.6,$?ZWO"[[^EY=
M;=]WWF;<;*8QWMO#/)&XXJZ0.RL/L8`]3![0,R;CNSHQ#BU<@CB#V]6G?(WX
MG?'+^9-A%K-Z';GQ\^8J8R.#;_=N+IHL/U_V[7?;HU#CNV<=&%I*'-5,Z"`9
M9FFE8O\`H]7''[[CO]Z#NO+O[IY"]WKI#8MX:QRN:1L"`*JW"&2I^``B5NXE
M:TZ&>Z;5LW-\&C<T2WWNG;<`4#F@`$OVT"ZJU\^M5GY*?%OO3XB]F93J;OS8
MN1V9NO''RTLSJ]3@-QXUR?MLYM?,JB09?"UJC5#,H4LO]D>_HFY,YYY7]P-F
M@W[E7=$N;%QFA&M#_#(H)TL/,5/V]05S!RUNG+5W])N4&DG*D95AZJ>!'V?G
MT7.O_P"`-9_U"S_]:F]B]/C7[>B>T_W*M_\`3K_A'6]1\ANY=K/3;'Z!^1'7
MF.[Q^-VY.B>GI:_963M!N39%;4=:[4I9MS]9;B$<]7MO-TD#F15A3]]TTDC5
M<?,O[E_>?YW^[S]YGF2ZV2Z=]E>[F=XQ\2TN6KI_B0CC%@,:U(KUEU>303V5
MMMNY6RW&V26L-4/$?I)W(?PL.(IY]:]/SE_E3YWI3:]3\C?BCG<C\@_B94N9
MLAF**'[CL/IEY295P?:N!@,U101T<9"+7%W,Y&IE6_OM-]VS[W_M_P"_>QV+
M+ND%OS"X`TDA5D>GP@$]DW$M%G30@,:=0QS?[<R62ONW+Q,^UFI90.^+!-&`
M'#T-`/(^O5/'^W'^!!!'^N#R#[S`ZB0BF#U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__3U>_?>'KG
MAU[W[KW7O?NO=='Z'_@K?[T?=9())H+HQT[8S7-/3AZ].HI*.PX`CK=WW,;?
M\)9>L#SSUCL0#C_L]ZOG_6X]\]+*Y@C^]_N3M*M/JV&#4U,5`*>I\AUD]NTB
MI[4K4'C3A_2/\OGUIV_&4?\`.2/QN/%O]/G2/Y_[^3M?C_7]YK\_B2+DWG'Q
M()!JLYJ54_[[;CZ=8^\NG_D0;9@_[D#_``];0?\`PK4KZJ'O?X;4OWF23'R]
M2=L2R45+7UE/325<>\=L+%4RT\,R4\LT*7"LRE@#P1[Q&^Y>;..+F^]>UAEG
M$L:`N5%`58$5;'$</EU,_OC=72/M%M!-H4C4?3#$<.A"_FP.9?\`A.Y\"G=I
MI3)'\6#Y9I7GJ7)P]7K,DLA:5W(^I))-S[3>S]O#']YOW,NEEC5(UO"%J`.V
M2HT^1XD#[.C?FAE'MQR_'XVN0Q-4GS'@OG/SQT>;^;&E-MG_`(3^X2CZP9*+
M;\>U?CY10IM]WIX6P-7G\4,I3PFG<$4]1+(ZRBY5@S`^XR]II/WA]XVYN]R4
MSRO=SFCBM2#@GRP"<^@Z-><6EMO;:Q^FD\,:(P2,8*FN>BX_R6S'E_Y'_P`K
M<7OP2S[+H\/VM%MZGS#&IQL5''L*LK8(Z%)[JD,>?6X`/$PN/8Z]]I(+/[QG
M*3[+&@N?$MS((B-0)>E-*Y)*^7SZ)>3%EG]N.81=L7%9#G/D#C\_+RZ?OY7,
MTU/_`,)H>QZI)9XYUVU\C766EJ9*>H5FWE5@O%4PNDL3@_E2#S[(O=#_`!G[
MRVSK<VYC!FLZK(M*=OXE/^7HPV"-K?VYWV6W)5M<Y'EYJ/\`)QZ+7_*#KJI/
MY#O\QNIIJ_*0U5/0_(>6GJOXE6FIIY?[N%A4T]4\[5$,X*A@R,&O]#?V*??6
MTM9?O#^WEG`L1!2U![0JU>3`(]#3CTFY0E?^I/,,SW>J3PE_+]):'_!^?'/3
MO_PFZJ:FH^#O\PF26:L<';N^96,U945+-,>O<DTDJ-5RSE6E'U)N2?K[7_>K
M:*/GSVUF$B&-)(=15-&%E2HT\3@&A\_+I![4F6;;N9VGNBZ>%3/EV>G1&OY%
MO\U_HS^7KNOO[K+Y%G<6&ZW[BW>F[,;N[;N!K,_+B]U8I9,$*&NQN/CDKFH)
M\=J9Y4NJ.?IQ;V,OO$>RF_\`N(G+.\\H7EJ]]'%_922+$=#*&U*7.DFM!HXD
M^?1%[>\[;;RT^[VVYA_I3)Q4:J4KD@?;^SJW_LK^6K_*>_FO["[L[@^$6Y\?
MLOO)_P"+[@RN5VEDLK@89]Z91:C*K6=D;0K:J;)U-'GY4=I+M#&[>H``6]P9
MM/NK[P>RVZ;'RYSUL\PVAG5*S1JNI?(PN5I)0?PUP./0VO>6.7.;XK[=^7=S
M5KDH>S-!7C@GMJ:YIQZ%?^1!MJIZ^_E(=W8S"4L5+V#@^V?D3B=PS4;(U='N
M["8_$4RQ25$8UN:>R/&.-.OCF_LG^\%=S[M[W<M?4$S;5<PV;BI[525C\2^5
M:&HX]&'M[:/8\G;G`K+]7&TBD@YJJT%3\APZJW_X2T5V<F^;/S/C2HR$F-J>
MNZ>MW!'43SS0S9-^WLU&E1()'9%K#4Z@S$:RA(O;W,_WM[3;X>1N3@/`:Y6X
M41^&5/:(Q4'3PH!P/IT$?:*:X_?6\"=RS%"#BN*)0GY?/UK\^EA_*,I]OT7_
M``H!^9M-MJ.G3%18SM=A]H%6%JZ7L<OD@B)Z5:*M+JUOJP]EWO3<2C[MW)`G
M5WDU6Q)H3CP_Y]6Y$MUAYYW)(R='BW&`#0#].E?3K'\$,KDZ[_A3?\F%K<KF
MJGPUWR"I*:*JRU;44<5'39;$I34,5)+,T$5/3QFR*JA5_'M)[F6&V6WW7.5+
MJSM8X;R6.P-%%2[:'JSD?`Q\PV>E7+]PY]T-V@%T3`)9<'C6@QZ_EPZK>_X4
M=K_V-'[!/T)ZWV0/\#^YD^2?<T?=:K-[.6D`E_Q@W,E4_9FO^3H`>[S`\T3*
M/A`3_`U>J2=K5FX,9G</EMH5V7H-U82O&;P59M]IH\WC\CAU&1BR6.FI_P!U
M'QOVPG<BZA4]5UN/>15_#:7EC+;[O;)^Y&C*GQ*4K2E-)S2OGZ=1SM[[C'<+
M+MROXE1PK_DZV,_@C_PI(^8_6>_>NMA_)"HQOR`ZHRV?PNV,MFIZ-8.V86S5
M=38BEKX,]%)#C:Y*>HJD9HC2&1P#9K^\.O<7[I>R;I8;GOG)=\EM):1-,ZF&
M1D8$%M*.&T+\L&@^74V<N>ZFXI?6]A?Q2,M`I!H3VC/D34T.,>E2>KA/^%07
M0W4F6^#^T?D-_=3`8SMS:G<G5^V<=NRGQD>-S]?MK>-=6'+X2K:G$,DJS?91
ME1*'==!`(]PC]U3F_>+#G;<.7YYVDVQK28%'?L+II^'54=W\^/0Q]S=LLI-I
ML]U2U471;```8ZD?)_TI`/19/^%(C*/Y?G\N<$27.0EM&"X.D=8;>\FH`C6J
MCDWN/<A_=CCBD]W?<V.1!J"DJ"O:OZS?BX"GD>B3W2667DWEON$;8K5A3X!C
MYUZ:O^$S$LM-\*_YD4]-)+!/3U.=DAEC9H989X^GZB6*:%Q9HV1@"K#Z$>_?
M>L$5Q[A>V0GD62U`4,O$4-R*C]E>J>TOBC8-^HP'Z1H0:T.D]$[_`.$Q$N/S
M/\Q[LS(9^HER.=BZ#WK58JISE=49.I6NJ-V;8-;4X^6OFFD@G\,KB0J?4&;V
M+/O;VL&U^TEG:;99*E@]ZK-H("Z=+Z0].&:4KT1>U$PGYSE2Y<R2A)-&*T((
M+$GUX4K4YZNF^8'9/\F'H[^8Q%WC\DMV=D87YA=6UFR]W1U=!M[=U?B<9!C5
MK7VLBB@H9J.HQ;HTOI5PD@'/N$N1-F]\>9/:>/EKE/9+:3D6Y5@3XD(<L2-5
M=3!QG@:4Z'O,6Y\F[7S2;[=-REAW!&%$,;Z20.(-0#C]E>BU]8?*+XB_-O\`
MX4/?'CN?I'<4&Y]LT?Q5WKAX\AF=NU>WS/V100[HD?QTN52*:IK*7"34SI-I
M%G&D<K<BW?>3>>^0ONU\Z\N\QQK;RF\A:B3*^F*1U!KH)Q6NH`X&3T30<P[)
MS%[@[9<;3+KM13Q"RE1K4,%I7CAC_J'1E/F1V1_)BZ3_`)B-=W/\E=X=BX#Y
M>=;UFUL_45.-P>[<EA,:Z[7I(<*V/?'T4U$]*^&F3RHCZ6=FU`,3["?('+_O
MCS'[81;#RKM%K-R;<ZUUF2%7D`J'=@S:P-0*TI7@14='?,.[\D[5S8E_NFZR
M+N$3#L".1YT%14>9\O7'1%/D!\T?B+\X?YV7\I3LWXL;FFW368+L&OV]V=EZ
MC:V5VU+/4R4M3+M.*1\DD39!H:".J4:01$J@$G582!LW(//O(?L#[EV'-MLB
MV+1L;?2RR``_VGPDA*-3CDU)QT2R[_L6_<_;/<;(Y9B4UD@KE7'\0%>VG`9.
M//JO+_A3FID_FD5ITN0OQWZB=M3-XPHJ-UEF"DZ+@?FWN6/N@P_4>UQAEFBC
MA^KFJV"]:K@`=U/GPZ`WO+,XYGEC68@>#'@?-?\`+U>9TY\F^S?A]_PFMZ/^
M0?3]7AL;V#LWK?`)@ZK<M":S%0C,=M9G$U7W5$TD)FUTU4VD:@3<6]XR7_*V
MT\[?>7W#EC<"QV^6Z:K$%?\`0A4GS%*=2S9;K<[-[:V-[:J&FC+8!&>]N%<'
MY#K44^:/\T+Y0?/V;KZJ[_SVR*W*=9U$E?L>IV7A'P3T^1$XKUJ:H/55/D>*
MLB5D(L5TCWG3[;^RW+'(,6\CE^[5H+M'C;XB2:D<"22/GU"',G.&X<Q/;W-U
M#)#)`*5ID`G-",5H>MP?%]6X?^;I\#?Y6O:%%31[SW#U7W]U5@^Z<YD(_)4'
M;FQ:+)8SMZ.=OURPU>>QM#(X)'D8@_CW@=/NVX^R/N1[D[)*["&XLYA'HP&,
MM#%@UTFC$$^5.I>7;DYUY8Y4NY%9KJ)U#$@XI3421Y<#T0_^:)\MZ'N[^=Q\
M&_BW_&(*GI7XR]]=3X[,8FI"+C9.T\IF:2GW%1Y&"X26"EQD%#&GDN`;V`O[
MEKV?Y'GV'V&]QN>;FT#;ENFWRK"Z'5(%HU"0,BI)-?LZ+>:=]ANN=]JV,=\%
MN\896PH.H5(KCB`*^8/5J/\`-SD_E,8[OSI3*?S`\SOO%=F8#:-+G.JX]MX?
M<V0P]/@<-NZHKJ>MU82BJ*2GR,&;IFX)63Q*O]FWN&?8G;_>+<>6]\MO;?:8
M;G;VE99_$,:N"P(X2$&FD^70GY]?E==RVR;?-T>UEC3LHK%6'GE2!Q\CU3]_
M.[_F4?![YK]`_&3KKXW=A9/>W8'7?R8ZPRDT>2V7G,!-3[*I&EQ=5++D\M'&
MKNM9)2!D%S,Q+V6W,V>Q'L_[A>WN^<V7_-5A':[7=6$U2)4;OJ&%$4DD4KG%
M.'0:YNYOY=WVSVK;]LO#)*K$5*LN/"=>+`9.,?GT)7_"H;*UU%U5\":+^(96
MGQU7C=SS5M#CLG54,%;/3TVT/!+.E/+''/)3"5BFL,%UFP]DWW4+:W',_/D\
M^W+>21F@J!5:L^16M/G]G6O=QG39]D2UNF52/X201IR3^7#SX'KK^:`T]1_P
MG>^#[U$[RR-%U+)+--++-)(17,RL\LS/*[$`7+$^]>TH6+[T'-JRR"$:[@4'
M`8X8^6.K<WF2/VPV?5J=]"`D_,'C7]@Z,%_PGC-_Y3/R]>[`?Q+MN11J8FW^
MB#38"_H_238>P_\`>K@5O>WE&L6B-6MR,4#CQ"*GY&O$]&/M<C1\D;FK2BC"
M3->':?\`!UIT?%3O:L^+?REZ6^1=+0ODINH>RJ'=[X^UY:ZD@BJJ"OA#S:UU
M?85\C)JO=@`/><G-O*K\W<C;SRO9N(9+ZT*J-!"5(!&10&O"H^WJ`]FW@;)S
M.EW_`&RQ25)K2H!XBM?RZWA]Y_)C^1O_`#D,IUGM#LZMIJWM;+PI@^O:W>&*
MS>QMY8#+9-(_+MS;F=R,\.(ER4U2NE"L4HFT`K;GWSMLN2_?K[OMK=WMKMK_
M`+MU'4(]$R`5RS4J5%!QQQX'RR.;=>2_<!?I?K_!OA0,&#*V/+R!%?,'K5)_
MG"?RZU_ER?)Y=B;=W-D]W]4]A8.+>?6F8SM9-D,_C\;-5U-')MO.ULW-?78V
M2C9S4*%1XG2RBWO-GV&]S%]SN5'NKJT\+=(3HD-0BEZ`U&!0$'SX=03[@\HO
MR[NT=O%*&MY%!4TH-/#^6/MZJA))/JY(^G-_I_3_``]SA'"JQ-%)+4'\_P"?
MG]O4<D:25#8KUQ_Q][4!%$:_`.O$X`ZY>W>J]>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7T:OY$J/+_`"F?B)%&C2222=SI'&@+
M.[MV_N8*J*.68G\>^%?W]E:3W_O8T4F1K2$`#B3X46!UEUR(">2]C`%29;G_
M`*O'I;_S#OYL'QV_EPX*IQ&>KH^S?D5E<342;9Z2VS602SXS[F(1TV1[&K]-
M12;<H&682I2U2)-5QJ?%]-0K]W'[J7.ON-N%IS'=L^W[%%(#XQ!`-.(48\5O
M(JOP$]QQ3I=O_-6T<H0^+?SZ]R([85.<@4+\=(H:\,BE,GKYVW>_<.X?D'W1
MV?WENW$[<P.YNU=X9/>>;PNT,<<1M?%UV3,2M1X/&-+.:.ABBA6REV)<LU^?
M?;KEG8+7E;E_:.7+&:62TLH%B1Y6U2,%\V:@J3]@].L3-ZW67>MRN=RFC1))
M&)(44%22305.*DTSPIU;K_("_P"RP.P/_$!=B?\`NAR_O$#^\!Q]W#G(GA])
M<_\`:/)U)?M%_N?O'_/(_P#S[U=QL3J^EKMBY'MOM#=>)Z@Z%VA2QR[L[6W9
M)]GC+4]**B;$[5A>2G?<FY9HD*PTM-)YC(18<>_E*^[G]U[W&^\+O.V[9R[M
M<T6S$HK7!5NX$"O@@9:GXI%J(SQX=#ZSL&G@>[GE6';HQ5Y6PH`\A_$QX`#-
M3U1%_-/_`)H6U/F)M_9'QVZ0V;64/Q[Z<R`EVMO_`+!IHJKMG?=;322!<Q4U
MQC@K<'MZJ#DQ8VH62>);!W-A[^L[[IOW6XONZ\J;98W>^W5WNT=KX.AI3(D:
MD"JLW"1P1AQ0<<9ZCGGOGBSW:TM]BVB/5ML)KXD@K(S4(P?PK0G&?*IQU297
M_P#`&L_ZA9_^M3>\Q$^-?MZB^T_W*M_].O\`A'6Z7\D=E;N[%[=Z>V9L3;V2
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M_-9;.UD=/%69G(U63JHJ.(04D<]9*TLB4T()$,"LUE6_`]]U+2VCLK6VLXF8
MQ1(%!8U)`%!4^9]3UC/>W4E]=3W<JJ))&+$**"I))H/(9Z:_:CI+U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU__4U>_?>'KGAU[W[KW7O?NO=>_K?Z$$?[?WH*%D\<$^*(V5?3NIQ'GPZL&(
M4J/,C^75_P!EOYPG4&1_E![0_EMQ].=GQ]A[<V;MS;=1V2^6VH=CU-=A-Q39
MF6M@HA4?Q]:.>FE\:QM%K#\EK<>\9;?V)WR+WLO_`'2?F&U.VSS.Y@$;>*%=
M-&FNG2#_`$@:@?#0]3%>^Y-I<<E#ER.R<7/`L2"--2>%*UI3\\UZH\ZEW90]
M>=I]5;_RM'5Y/'=?]C[`WOD,=CY(8J[(T6S]U8?<-70T,E1_D\57608UHXFD
M]"NP+<7]Y"<P6%SNO+V\;'93+%]3;R1AFU,`70J":U-,YIGTZB_:MP_=VZV=
M^%JL<H:GYUZMF_G0_P`T#K7^:#V%T5O7K?K#?_5T'4NS=[;8RE)ONOV[739B
M?=&;P^5I*G'?W?JZR.*&DCQTBR^5@S,ZZ18$F%/8#V=WGV<BWZ/<]ZM;U;R1
M&`C0T72&K4NHSW4%/(9J3T._<3G>RYOGL)+6S9!$E#J(/XJ^7RI_/I9?,3^;
M)U1\EOY8GQT^!VW.I.R=M;XZ3CZ?3*[\SV5VQ4;/S)ZVQ4]#E3C:/'3R9M1E
MJB773>5(_$@L]SS[IR%[,[ORC[P\U^Y=[O=M/8;@;@I`J'4GBOJ74673VC#4
MJ#04ITMWSG_;=RY4V[8X+!UN(8]);4*94KC]O0\?$7^>IU3M/X1_[(M\ZOC?
MNGY%]8XG!)L_;]?LS,XC'Y&MVC`[345'N7^.9+&O_$\9-(6IZBFD!72M[_@&
M\Y?=RYBG]PI/</VZYO@VS<I',C+(AH)#6NG0C`(1Q&GHTV/W3L?W0-EYDVOZ
MFS0`+D#`%*$'C3@#6M.D=\H?YT'2]3\'Z;X%_P`OCXW[M^-74V52KQ^\,EO?
M/8W+YYL'4U@R<M)@:C#Y/*22U5?7+:IDK)6U0L54#\K>3?8'F9?<*+W#]T.9
M;/=MRCTE5A21`644!)*QT"BE*"M?/IGF'W'V6ZV6YV79=H>&"9BS'7DDFIK3
M.:FN37KKXH_SF^G?CU_*MW9_+YS_`$MVAN#>VX\5VK00[_P>4VC3;0IYNP<_
M59G'2O25U4F96'&QSJDRB%BS*=!L1IMS7[`;]S![NVGN19[_`&D%A%-$_@L)
M7>D?$5;4"3Y5-!7ATUL_N-MFW<HW>P/MSM/*'SKQ5Z#(-3Y'S]/4]!%\(_YJ
M75?Q8_ES?*+X4;IZH[%W7O/O^E[1I\/O?;V4VS3;4P/]_<,^-QIRE'DI8\NX
MQD[!Y_"LGD064`\@1^X'L_S#SI[M<J^XT6_6D5EMQMJQ-&WB-X#ZFII&CNX"
MO#B>F=C]P=LVWES==HEVYS-.M`013"!<^?$5ZG_RL/YKW5?\O[X[_)7IC?G4
M_9'8.<[TH,_08?-[-RFV*+$82/,[7K,`O\4@S<\%:[13U*R%X=8T*0%)(M3W
MM]G^9O=OF/E??H.8K2T&WLM5,;58*X84TJ16@(H:<>/27DSGK;^7+#>+:XL7
M>2XCT@A@*=NG..'08?`+YK?`OH/K#N?K/YC?"W,?)BG[1WI'NG&Y["Y3$4.6
MP%$E"]#_``=)\AE<14TL;:A*6IID_<N2#[5^Y'MU[G\R[UL.Z<F\^V^VQ6EH
M(F5XV)9P1WC2C+2@(R*YZKR[S9RM:VEU:[UL)FUR!@P8`CB?MXGUZL&Z8_G3
M_P`O'X0=:=VXS^7W\$>TNK>T^W,:D0W!V+O'`9G;,&3HZ6IHL,V4%!GLCEWQ
M>&IJR7Q1PJ)&>Q=FYO&&_P#W?/=CGW<N79?<3W)LK[;+*8$HL<FHQU[E4E%`
M9@`*\./0LB]S>5MHLKV/8]EF2YEC*AFDU4J2?,G`+$T!&3T3?^5Q_.J[._E\
M;CWW@=Z;-'<W1O;&ZLOO;?6UUK11[JQFZ<S,\^0S.T9:J2+"-494LL=4M:&1
MHXTTV(/N1?>#[OFR>X45C=\MWS;;O%E&D5OJ&J(0H!I60K64LN2&!KG->@KR
MC[D2[`L]M=6QDM9FJX!I6M:FIK0_D0:FO"A.GL;^=]\"/B5M3OC*_P`O[X)=
MA]0=X]X1U[Y'>6^]U8+);>I,CD:NJKVKY(<=N#*Y$1XW)5LE734\:"+[@C5Z
M/3[B_=/NW^Y_.%ULJ<\^X=A<[59,-,<<<@JHH/\`?:=S``%B>'SST+1[H\L;
M;:WW[FV*1;N9"NHN*\*#(S1?("E*8ZK,_E8_S&,#\%?F-OWY6=T;0WIVW/O_
M`&KN:@R]#LVMPE!FIMU[IW&NX\EG*B3/2T]')23U1D+1JZ-J;BP]S-[M>TD_
M/O(^S<G\O75M8"U*$M()&5@BZ0`%K3]G0(Y-YTL-@W-]POK*260ELAZ'NIQK
M6IQY_MZ%/XY_S1NK^DOYM/;G\Q3+=6=B9OK_`+&JNSJG%]<XW)[:CWMBFWY6
M4=50FOKZJ6'`3_P\4Q$PC===QI(^OLNYP]G]^YB]E.7/:JSWVUAO+,6P>=HV
M*/X`8-2BEQJKBOY]+=IY^V^QYRW'F*;;V-O-)(P4,*C52F2,\,X'18?YI/S/
MV;\_/EUN+Y'[#V7NKK_;^;VIMW;\>V]Y5F(KLW'5X;[DU-7)-A)):!:>H:H_
M;0,S*!8D_7V,_9KD;<_;'DFUY4W'<(+J:.=Y/$C4J.ZE!W`,:4_V.@]SOS+9
M\S;Q-?VMHT:,!Q()J*Y/[>G3^6'\VNI_@=WUD.X>TOCQB._Z6MVV^VL?35ST
M9RNU(*V:5,S7X"ERY?`SUV4Q=1)3,:J*0!&XM]?99[R>W_-?N7RX-DV?FQ=N
M?Q-1-'TL/X6T484XC214X..G.2N;8.6KKQ+NQ6:.M1P!'[0>K=L?_-M_DE8G
ML_']S8[^5#ORF[(Q.43-XW/1YC9HAI<K%(TT-6F$.\#M\/%,VI;T;*IL0+@>
MX73V.]_8]CGY;7WGB_<TL7ANE)>Y*4H2(]5*8X]2*GN%[?PW`O(>4Z7>LOJJ
MOQ$U)\_/Y#JO/^:K_.)[<_F8Y'%;1J-K4G6/0VSMP4^X-H[%IJR6MS66R='*
MLM#F=[50DDH:C*414B(4MH4#-8<^Y)]E/8/9O:9)]PN;I;[F.>(H\FG]-*_%
MX2L*YXU:IZ"'.'N5>\QW,'TT?A6D9:BFAJ"M,GUH37'IT?+L?^=?\#OEE\5^
MENA?G%\,>XNR=S]0X2DCHLWL#=^UL1M^GW328R/#C.8-\AF*++Q05-%30B2*
MH20$@\$'W'.S_=\]SN3N=>8>9^2O<6SM[7<+C4R2Q.S>%KUZ&`C(U5KD$#AT
M*9?<_8-TY=@VG>-G=[E(Z!U8"C4(##TQ@C/V]%?_`)7?\V;I?^7YT[\P.J-R
M=-]G;UC^1&X-RU>QZO:F7VO3T^TMNY7:M=MG%8S<2YJIAFJ:^BBGB,DM/Y(]
M*-922/8N]VO9#F?W+W_E'>H^9;.W_=R('!C:KLL@<E=*D9H<-3/G3HHY.]P]
MKY;V[<[%MN=C*,'4!^&F<<*]5>_$OY9]J?#'O_:WR(Z?JJ:/=>V*^<38?)F0
M87<VW:QS_$-M9W[>U2:"N0AG,1#"1%(-A[E_G[D+:O<CE&;E3F0EH:AHW4!2
M&48+4`K0YZ`.T\RWFQ[L=TVQS$Y9B1@\>(SY'@?EU?1WA_-__E*_+_=^U.Y/
MES_+5[-WWWCBMO8?#9[.[:WG@\?M[)_P=9#34(0;LQ5=7X:EEGD,`JHS,J.5
M8M[QOY=]A_>KDG;;C8.3_=*RMMC9V*J8Y"R@^8K&X#4`K0TKGJ6+WW&Y,WPV
M]WO?+TDE^$`<J]%;U!R*BOKY8ZJ.[@^=&!?YUT'S-^)O3V)^.,&T<[C<MLO8
M%!.):2I3'QTE+5+NDT<CTZ2;AQE&M)6I1:(3#=D`<EC-_+WMG=O[<3\B^X6_
M-NL]Q;R)+,JT'B,&T.NL:M*,0:-4XZ`%]SFD?,46Z[%M\=M9HX(3C51]E`3D
M^G5N?=O\X3^4U\OMT;([>^7G\M3LC?G=^W<+C:+,YW;&\<%C]N9.KHVBJI*?
MQC=6)KLEAXZ^.\`K(WG6(!&8K=?<%\O>P?O7R=87.R\K^Z=E#M#LU%,<E55J
MCM_3:A(H6H0-52/+J0KSW)Y+WETNMVY<<W>D`E7H&X_$!0'B1FN#QSU5GOGY
M\=94?\Q7JWYO?'7XV[=Z2VEU+N[:NX<-U305CM_>"GVQ0U>*C.>E@G?'TV4J
M,;6N"])XT:3EK^Y>V+VKY@7VNWSV]YNYN-]<WD;J)E#:5+Y&'[B`>@%=<WV$
M._P;ELVV^#:Q.&5215:,K$@C&=/F*='0_F;_`,S3^71_,*QVX^R(_B%WGM'Y
M6U>T\!M/;':F9W=M&7;V*QN`EJY::BR.+QF7E:LI`:^476F$AN#<?3V"O9_V
M>]UO:J\L[>'GS;YN6U=VDA\)];:^)4LE`<`BI(]:]"?F_GKE3F2TF<;1*NY%
M0`VI:8&*CSIY''1F/B)_/E^(/3?P$Z9^$OR"^)?:W=E'U[M2/`[NFI\AL-]G
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M`9!J*4K^?5*/9/>>^NQ_D#O3Y*5>5JL=V;O'LFL[/?-T[AZJ@W(U:M3C:ZG:
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M[FH]P9#"RST63R=#44-4U.662JDFG28`*RQDK[DSVY]LN?\`E^;?Y^>N>UW4
MW<)2,*'`0E::CJ`''R4#'$5Z".^\S\JW,UC)M.PM#X6JO?754$`GAD5KT.O\
MWC^:WU9_,@VG\<-O===3]C=:U72-/FJ;,U6^<IMC)0YN+*08&.+^%)@99FCD
MA?$R,S2A`PD4!18DEOLG[,\P^TNY<TWTV[V%VFX$4`68%:,YS6@_%P'ITIY[
MYYV[FFUVR.WL72:%2"2V.%,`4_S_`+.LWRV_FO\`57R+_EC]`_!#;W4W8^W-
M\=.IL=<EOW-Y3;$^T,L=JS--7_845!/)F+5S']GR1Q^,<-J^OMOD_P!D]\Y:
M]W=]]R)MVL9;"[:9A`%EUJ91@U/;VG)R:^5.G=\Y\VS<N4-OV"&PD6YB506+
MU&*UH/.M?/ATO/Y2?\Z+K_\`E^=$]N_'?NGI+>';>P^R,_D<S15&P\I@\=E*
M.ESFWZ?;F;P>4CS]724\U#4T<3LCQ-Y5:0B]K6*?>C[O6\>YG,NU\S[/S3%:
MW<"@%9E9A52671I!Q4Y!_+I_D7W'M>6MMNMJW#;S-;2>C4.10^1P1]G13MQ?
M*#^7/M3YG]"=_P#Q\^'W8>WNC^OJS)9KM/I/L;<V!S<F^\]5RU$=--B)J?(9
M"@IL?2T%4X\-3(R^4*;6'L9VO(?NE<>WN_\`*^_<^6\G,,B@6=S$LBK!2GQX
M5R./PYZ0W7-7*@Y@L=PL]A/[N6@>-F!J/,#C3RIT?7$_S%_Y&&![MVQ\AL#_
M`"PN\<!V7M'=%'O7#2XG?.U(\#3[HH)#-2Y48>7=K4D<M/,=2K$D<=_[/N/F
M]J?O$OLMQR]-[M[?+M<T31/XD<C.8V%"`QA)X>9-?GT+(^?O;Z&;ZB#EJ9'X
MT$A"D@AA50U/B`/"E16G5;7\TS^8KN?^9/\`(J+MJIVNW7^P=IX!-G=;;(EJ
MDKJ_';=BJJBL^^S]1&TE'+N"KEJW68TY\.@*%`L?<P^RGM9MOM)R;/LTDWUG
M,-R=4TH%(=5*4C4]^D`#XL\>H^YUYUDYLOUG:WT6T>$6O`5K0D<:X)X9ZK7M
M;CW*(4@`?+H!DU)-.O>]Z3UKKOW?KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U?IT]_/0W]\8?Y;74WPN^-NR*[:7<NU%[!QV[
M.]]P3XVNI,1BMX[SS6Z::JZPQ4#2R09R.ER<=-.^3A=$*N\7)4KBSS)]V/8>
M=_>2^]SN<+B*XVWPHEAME!U'1&B,LQ84T$J6'AD-D`F@-9AVWW0;9>5;/:-L
MM2NY(TWZC4(42.S#2*BAR`20PQP-<44;HW1N3>^X\ON_>6>RVZ=U9^J>NS6X
M<]D*K*9?)53DDR55=6RS5#JNHA$U:(UX4`<>\G+&QL]LM(+#;[5(;*):(B`*
MJCY`?S/$\3U%-Y?7>X3R7-Y<-),S$DL:Y/$_ZO(`<`.F+VJZ2=6/?RO_`)K]
M?_`_Y"9;N/LCKG<O:6WJ_8&X=I#:FV<AC,9455;EJ.JIZ<Y&IRDD2?PEGG"S
MB)A-XRVFYL/<*^^_M3-[Q\E-R<EY!#;RR_J^*'*O$1I=*)FI4D>F?+H?<@\U
M6'*U]=W&X6CS0R1%:*0.)'&OR!'2%^;7\P/OKYR[NIJWL+*Q[7ZOVQ$<;UKT
MAM&:HH.N]C82-T:*&+&(8AG,K,8E>6LKA45`>X1PIM[6^T'LGR'[+<MV?+_)
M^T11O&BJ\VA0[Z1I%*`!`!BB@:AEJG/23F?G3<^8I!'K\';$/Z<*X5!04^9(
M(KJ)K4FE.'1&_<N]`SK#41&>GGA!"F6*2,,;V!="H)MS87][4T(/3D+B*:*0
MBH5@?V&O6P-\H_YYVX=[=4[8ZS^)/6>0^/\`G,GU9M38'<W<V8KL?D>T]TMM
MS;./VO-B=GY#'-/2;8VM6TE!Y/)#X,@)&/K`X]X;\@?<_P"4M@Y]YA]Q.</I
MMQWNZO'FB54(159S(HD+C465J=JGPSY@]3+OGNJ9=J@L-AM&M[EH$224D%R%
M4*0I_""!DTKG!'5`<TT]345%75U%365E7,]165M;435E;65,K%Y:FLK*EY:F
MKJ9G)9Y)'9W8DDDGWF*B)&B1QHJQJ*````#T`&`/D,=0W//-<RO-/(6E8DDG
MU.3]GY=8_=NFNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]75[]]X>N>'7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?
M_];5[]]X>N>'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
:Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g238735pageformat.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g238735pageformat.jpg
M_]C_X``02D9)1@`!`@$!+`$L``#_X0C617AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````4````<@$R``(````4````AH=I``0````!````G````,@```$L````
M`0```2P````!061O8F4@4&AO=&]S:&]P(#<N,``R,#$Q.C`Y.C,P(#`T.C0S
M.C0X``````.@`0`#`````?__``"@`@`$`````0```,B@`P`$`````0```"P`
M````````!@$#``,````!``8```$:``4````!```!%@$;``4````!```!'@$H
M``,````!``(```(!``0````!```!)@("``0````!```'J`````````!(````
M`0```$@````!_]C_X``02D9)1@`!`@$`2`!(``#_[0`,061O8F5?0TT``O_N
M``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43
M$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-
M$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#/_``!$(`!P`@`,!(@`"$0$#$0'_W0`$``C_Q`$_```!
M!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$`
M`@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R
M!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5
MXF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7
MI[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q
M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S
MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_
MV@`,`P$``A$#$0`_`/3<C*V.]*H%UK@X;HEE9#=[#D0=S&.0GWN%&^RR"6AT
MAS6-EC?6>:G.]_IO_/W_`)BS>G6>L^W*AEC[GO<ZZNLM#A2]M6,RS=8RSU*7
MN]3VLV65+0=C69%[O>:Z6P'1])Y@.^E_)]GTM_\`UNM5..>2R+U/I`/Z-?R_
MEP-J6*..7"?T?F)&O$-Q_C+'/++6U[MSGO=["`Z0VOU7U8[Z?;N8[_N3]-7*
M+VW5A[06D@%U;M'-)&[;8W\QZR<CI=<&DDV,?#;6.]P(<6[20ZRICK/4]*[U
M[/4O_0OI_2>HA='O]+J`IL<QMN72;+6>G%K[6.])V1;;47T-;8VOV4[_`&)0
MRSC,1GM(UJ?\'_I+I8<<\9EC/J@+(K_"_P"@[Z2S^L9^9@4LNQJ*[VN>RIXL
ML-9#K7UX].W;5=N;OM_2JEE?6?[)9D8UU`.70['8VMKG%CS?Z>_]-Z6VMM3K
M';/4_G=GYBMM-W4EC,Z[DG*K#\0-PK\JS"JO]2;/4J]5OJ64;-K:;+<>VMGZ
M;U/^#_<KX/UM9F'IU;<5S;\W?]IJ+Q./M8^RO?[1O^U[/U7^:]6K],DIZ%)<
M_1]9LFS%-CL1C,I]M-->&;7-M99>2`W.9;CU_9V,:W=ZM7VAEW^`]1/9]9[<
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M++?1<^QEI]1WV?U1[6=,V?:?2V/]1ZLXV5G/:STH<RP-+;`'%I#]]C7-]N[Z
M#=]GKUT^D_V;[_T:T<S[/L_2?SNU_H[8]6=IW_9I]WJ[/W56'I[SL]/U)KC?
M/J;MA]3[5Z?N]3[+]#>J``$C[<B1?Z/%=5_*/\LC?G*7`/<A$&M-8]_Y3_\`
M77MKM#ZJ"]Y<^QWZ0EWMDAH?[]S=M3&_\(VO9Z:%TJA_VJRX%[**V"JIOZ/T
M;08M=F5-I#=CK7_31A'M]2?2]3V>G]'TO3]OVN?\'_6_X-7*?1])GH;?2@;-
MD;8[;-OM4F,`RB2:H^F/[S$3(1R``&QZCIZ?[K')Q:,JL59#-[`]E@$D>ZMS
M;JG>V/H6,8Y!MZ5T^[[1ZM6[[6ZM^1JX;G5;?1=H[V[/39]!6TE;:K09T3IC
M,PYK:8NWNM'O?L%E@V6WLHW^@R^UKO?<ROU%*GHW2Z/1]'&8PX^PUN;(=^BK
M=BT;W_3M]+'L?6SU=ZNI)*<T?5[I/IVUNJ?9ZWIA[[+;7V14XVXX9?98ZZKT
M+'>I5Z=GZ-ZG3T3I=(8&T`EAL=N>YSRYUPV9#[G6.<Z]UK?:[UO45]))32IZ
M/TVC!HZ?52&XF,YEE%6YWM=6_P!>IVXNW^RUN_Z2A;T'IEAG8^MPLLM#ZK;:
MG!]T?:-CZ;&.8RYS=]E;/T?J?I/YQ:"22F@_H?3'Y;<Q]1-S7,>9>_:Y]0VT
MW6U;_2NOJ:/T=UK/54[>D=/N9DUOJEN98VV^'.!-C!6VJQKFN#JWU^A3L]+9
M]!7$DE-']C=/+-EC'7?HK<<NNLLL<:KBU]]3WW/>][7N8SZ7T/\`!ICT3ISK
MZK[&/M=06.J;9;8]C7UC95<*++'4^NQO^&V>JKZ22G__V?_M#9!0:&]T;W-H
M;W`@,RXP`#A"24T$)0``````$``````````````````````X0DE-`^T`````
M`!`!+`````$``0$L`````0`!.$))300F```````.`````````````#^````X
M0DE-!`T```````0```!X.$))3009```````$````'CA"24T#\P``````"0``
M`````````0`X0DE-!`H```````$``#A"24TG$```````"@`!``````````$X
M0DE-`_4``````$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8`````
M``$`,@````$`6@````8```````$`-0````$`+0````8```````$X0DE-`_@`
M`````'```/____________________________\#Z`````#_____________
M________________`^@`````_____________________________P/H````
M`/____________________________\#Z```.$))300````````"``$X0DE-
M!`(```````0`````.$))300(```````0`````0```D````)``````#A"24T$
M'@``````!``````X0DE-!!H``````TD````&```````````````L````R```
M``H`50!N`'0`:0!T`&P`90!D`"T`,0````$`````````````````````````
M`0``````````````R````"P``````````````````````0``````````````
M```````````0`````0```````&YU;&P````"````!F)O=6YD<T]B:F,````!
M````````4F-T,0````0`````5&]P(&QO;F<``````````$QE9G1L;VYG````
M``````!"=&]M;&]N9P```"P`````4F=H=&QO;F<```#(````!G-L:6-E<U9L
M3',````!3V)J8P````$```````5S;&EC90```!(````'<VQI8V5)1&QO;F<`
M````````!V=R;W5P241L;VYG``````````9O<FEG:6YE;G5M````#$53;&EC
M94]R:6=I;@````UA=71O1V5N97)A=&5D`````%1Y<&5E;G5M````"D53;&EC
M951Y<&4`````26UG(`````9B;W5N9'-/8FIC`````0```````%)C=#$````$
M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<`
M```L`````%)G:'1L;VYG````R`````-U<FQ415A4`````0```````&YU;&Q4
M15A4`````0```````$US9V5415A4`````0``````!F%L=%1A9U1%6%0````!
M```````.8V5L;%1E>'1)<TA434QB;V]L`0````AC96QL5&5X=%1%6%0````!
M```````):&]R>D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX````'9&5F
M875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E<G1!;&EG;@````=D
M969A=6QT````"V)G0V]L;W)4>7!E96YU;0```!%%4VQI8V5"1T-O;&]R5'EP
M90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/=71S971L
M;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H=$]U='-E
M=&QO;F<``````#A"24T$$0```````0$`.$))3004```````$`````CA"24T$
M#``````'Q`````$```"`````'````8```"H````'J``8``'_V/_@`!!*1DE&
M``$"`0!(`$@``/_M``Q!9&]B95]#30`"_^X`#D%D;V)E`&2``````?_;`(0`
M#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,
M#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`
M'`"``P$B``(1`0,1`?_=``0`"/_$`3\```$%`0$!`0$!``````````,``0($
M!08'"`D*"P$``04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"
M!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,'
M)9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34
MY/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'
M!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T
M\24&%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%
MU>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`]-R,K8[T
MJ@76N#ANB65D-WL.1!W,8Y"?>X4;[+():'2'-8V6-]9YJ<[W^F_\_?\`F+-Z
M=9ZS[<J&6/N>]SKJZRT.%+VU8S+-UC+/4I>[U/:S994M!V-9D7N]YKI;`='T
MGF`[Z7\GV?2W_P#6ZU4XYY+(O4^D`_HU_+^7`VI8HXY<)_1^8D:\0W'^,L<\
MLM;7NW.>]WL(#I#:_5?5COI]NYCO^Y/TU<HO;=6'M!:2`75NT<TD;MMC?S'K
M)R.EUP:238Q\-M8[W`AQ;M)#K*F.L]3TKO7L]2_]"^G])ZB%T>_TNH"FQS&V
MY=)LM9Z<6OM8[TG9%MM1?0UMC:_93O\`8E#+.,Q&>TC6I_P?^DNEAQSQF6,^
MJ`LBO\+_`*#OI+/ZQGYF!2R[&HKO:Y[*GBRPUD.M?7CT[=M5VYN^W]*J65]9
M_LEF1C74`Y=#L=C:VN<6/-_I[_TWI;:VU.L=L]3^=V?F*VTW=26,SKN2<JL/
MQ`W"ORK,*J_U)L]2KU6^I91LVMILMQ[:V?IO4_X/]RO@_6UF8>G5MQ7-OS=_
MVFHO$X^UC[*]_M&_[7L_5?YKU:OTR2GH4ES]'UFR;,4V.Q&,RGVTTUX9M<VU
MEEY(#<YEN/7]G8QK=WJU?:&7?X#U$]GUGMQW,9E8>TUY+\?.<RS>VIK65WC,
M9[&.MQMF31ZNYM+Z/TG^B24[Z2Q\CKSZ>C_M(TM#C?Z&QUD,$W_8_6?<UC_T
M?^&]M:IN^MMOHTN9C5EUME[!:+'OH<,<,W78]N/CW77UV.LV?T?Z==O]M*>D
M263;UQ]5>2\X\_9LNC$/OT/K_9IM^A[?3^U_0_D*M9]8>H459]E^)2!@6UXY
MV7.=NLM-'IN_HXVTMKRMUGT[?^"24[Z2YW,^M-N)30]]6.#=5?<YUESZF?H'
M-K]&HW8PM=?;O]GJ4U_]<5FOKV0_J->(_%;B5V"LL=E/=4^S>QMKVXS/1LHM
MMH<_TK*/M/K;V?N)*?_0[.[$OJRG;M]FUQ`LM]%S[&6GU'?9_5'M9TS9]I]+
M8_U'JSC96<]K/2AS+`TML`<6D/WV-<WV[OH-WV>O73Z3_9OO_1K1S/L^S])_
M.[7^CMCU9VG?]FGW>KL_=58>GO.ST_4FN-\^INV'U/M7I^[U/LOT-ZH``2/M
MR)%_H\5U7\H_RR-^<I<`]R$0:TUCW_E/_P!=>VNT/JH+WES['?I"7>V2&A_O
MW-VU,;_PC:]GIH72J'_:K+@7LHK8*JF_H_1M!BUV94VD-V.M?]-&$>WU)]+U
M/9Z?T?2]/V_:Y_P?];_@U<I]'TF>AM]*!LV1MCMLV^U28P#*))JCZ8_O,1,A
M'(``;'J.GI_NL<G%HRJQ5D,WL#V6`21[JW-NJ=[8^A8QCD&WI73[OM'JU;OM
M;JWY&KAN=5M]%VCO;L]-GT%;25MJM!G1.F,S#FMIB[>ZT>]^P66#9;>RC?Z#
M+[6N]]S*_44J>C=+H]'T<9C#C[#6YLAWZ*MV+1O?].WTL>Q];/5WJZDDIS1]
M7ND^G;6ZI]GK>F'OLMM?9%3C;CAE]ECKJO0L=ZE7IV?HWJ=/1.ETA@;0"6&Q
MVY[G/+G7#9D/N=8YSKW6M]KO6]17TDE-*GH_3:,&CI]5(;B8SF645;G>UU;_
M`%ZG;B[?[+6[_I*%O0>F6&=CZW"RRT/JMMJ<'W1]HV/IL8YC+G-WV5L_1^I^
MD_G%H))*:#^A],?EMS'U$W-<QYE[]KGU#;3=;5O]*Z^IH_1W6L]53MZ1T^YF
M36^J6YEC;;X<X$V,%;:K&N:X.K?7Z%.STMGT%<224T?V-T\LV6,==^BMQRZZ
MRRQQJN+7WU/?<][WM>YC/I?0_P`&F/1.G.OJOL8^UU!8ZIMEMCV-?6-E5PHL
ML=3Z[&_X;9ZJOI)*?__9.$))300A``````!5`````0$````/`$$`9`!O`&(`
M90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T
M`&\`<P!H`&\`<``@`#<`+@`P`````0`X0DE-!`8```````<`"`````$!`/_A
M$DAH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I
M;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED)S\^"CP_861O
M8F4M>&%P+69I;'1E<G,@97-C/2)#4B(_/@H\>#IX87!M971A('AM;&YS.G@]
M)V%D;V)E.FYS.FUE=&$O)R!X.GAA<'1K/2=835`@=&]O;&MI="`R+C@N,BTS
M,RP@9G)A;65W;W)K(#$N-2<^"CQR9&8Z4D1&('AM;&YS.G)D9CTG:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R<@>&UL;G,Z
M:5@])VAT='`Z+R]N<RYA9&]B92YC;VTO:5@O,2XP+R<^"@H@/')D9CI$97-C
M<FEP=&EO;B!A8F]U=#TG=75I9#HW,30P-F8P,BUE861B+3$Q93`M.&4P92UC
M-S1A8V$T-3DY8S<G"B`@>&UL;G,Z>&%P34T])VAT='`Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]M;2\G/@H@(#QX87!-33I$;V-U;65N=$E$/F%D;V)E.F1O
M8VED.G!H;W1O<VAO<#HW,30P-F8P,"UE861B+3$Q93`M.&4P92UC-S1A8V$T
M-3DY8S<\+WAA<$U-.D1O8W5M96YT240^"B`\+W)D9CI$97-C<FEP=&EO;CX*
M"CPO<F1F.E)$1CX*/"]X.GAA<&UE=&$^"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H\/WAP86-K970@96YD/2=W)S\^
M_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!
M`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#_\``$0@`+`#(`P$1``(1`0,1`?_=``0`&?_$`:(`
M```&`@,!``````````````<(!@4$"0,*`@$`"P$```8#`0$!````````````
M!@4$`P<""`$)``H+$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$4
M03(C%0E10A9A)#,74G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W
M1V,H5597&K+"TN+R9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY
M>H6&AXB)BI25EI>8F9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7F
MY^CIZO3U]O?X^?H1``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R
M811Q"$*!(Y$54J%B%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS
M@Y-&=,+2XO)59756-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6
MIK;&UN;V9W>'EZ>WQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI:
M:GJ*FJJZRMKJ^O_:``P#`0`"$0,1`#\`W]9)(XHWEE=(HHU9Y))&5(XT0%F=
MW8A555%R3P![:GG@MH9;BYF6.W12S,Q"JJC)+,:``#))-!U9$>1U2-2SL:``
M5))X`#S)Z#*N[0I*/LC;?74>VMT5XW-@*S/TF[\?C#5[/IHJ1PHI:S,0NT$%
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M4"7/CDEY%:-5&-3!B]V"SV;:=YLM]VS=+?G6WGAI&R*D$4$B!ZW`9?%$KZE,
M8JBT.02:#GU_V;CM^8BIRTN#W#LQH-P9/;T>,WK0I@\E5U&.J#"L]'3RS.*F
MGJELR-&S`W(!8"Y<]O/<>TY_V>?=VY>W+:--_):)%N$0MY9GC)H\*EB72102
MF`QTM0$+4UYPY,N>4=Q@V\;O9;B'LX[@R6<GC1JLB@E78`:60FC!@*8J`33H
M2O<C=`WKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]#<
MG[M[1W=6]P;8^.)ZDW+GNN.TL%-0[B[(P.0J*6;;L4U/E3DJT2TL;P8^DPCT
MU()6J)(VF-0P0$(U\8O=[F+=^8^==M]BMP]N[Z\]O^8;$I=[A;3M&\(=CA61
M3X>@(6D+E24^$$,`<D/;+DCEZ'VZYA]XT]P[*SYTV"Z#V^WW$:LMPP,7AK1R
M#*TVJ;2(U8(8AK(+"@@=98>BV[MC`[1VY6[DPFR-J3[DZ_J\'O?&30YW>&3&
MJ#'Y+%9ZKE6HBI9)A*T3(/'(C?V=(]F/(*;+MW+G+?+.PF\VKD&SEN]I^AW.
M!DNMPE&I(S%<2,&\.2CLKIB1>&D#`1YSO;O=MWW;?M\2TO.:MP2WOUN+*53#
M:1GNDCD@0%=0&D%2:J1YZND7N+LO';+;"TM-#M[;D^VMEUU'E=KR8C)]@[QQ
M4NZ<Q'MK9D^,RN"%7CZ[$/GM$F4B\K2^,\VTD@CO>:MLY%V[EI5VO:MLM]LV
MNY3Z%DEW._@$TOTUHUO/;B35;:RK7B!RZQU##MZ/=JY-N>9'W-G>^O6O-P1H
MKP2Q6-G(MM";F\$L=QH=)A`"+9BH4L,5U#HK[=U;?@P^V=P[@P6RQ@^E]@=H
M-5=A;!ILQBLQL_M09^;;<U+LWJ!41]P8=C-354U24>G6<,RMH)O#EIS#R\+3
MEOF;F/;MM7^IMEN<1W;;8I;4VFX32M:2MM^S,4^JM4%Y;R/</&87=FF\10C`
MS5_4+=;J^WG8MKO-T&_\S[KMACVW<'AE@N]M\#ZJ,WV\@E;:?].2-(=0E\,A
M676*=0\5GJK=F0ZQZY[A/9?9U=L[:Q[RV3WM%*=@8/>N0S4D.X\+L2KQ-0M-
MHK!###0113?Y0QIV&D,S^U5C:3<['D?E7W4@WG?I]GLCOFV[Q#*UC!?R2(LU
MO:M&P5I'92MO1RLJRB1*!6%;;_;P\M6'.W.WMP=CV.QW'=5V&_V0J-PGL(H1
M]//?B;N7PB2\[R)V4EC()HO1WOC#W1O?O'9.5W7O;K+(=8S4VX\ABL-C\E).
ML^:Q-&51,Q'1UL4%=2Q/+JC_`'$"NR$I=?>2_L;[C\U^Y7*]YNO./(TVP[M#
M=/&('U$/&`"K*7"L2M2DAII#@A21UCS[W>V_+/MCS19;%RQSQ!OMN]E'++)$
M`1#*XJT+.A:-B!1NTDJ"`U#T9/W-74-=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=?_T=BSJ3,005GRFWEL_=_>W=]-NS>%#L#*=:X>GSNUL]A,
M?OG<V:RU+OBBR.9RNX\;%%044QHJ6>FBID,+*DB`2QNW,S;=TVQI?>BYV#F'
MG3F>/=+_`.GGL;(3V][;6\LQ8[A;RL60A)H6LT,"APC*A2)-4G73CGO;)S8>
MQ7+/,_*W*/*LVW[4U]%N4[V]S;W$MG;QPM82QPQ02DR/IGF262<^*SM'(YC<
M=6C8K)S8FLK<''5]B8FBV[C-M[-H(-WRX"DI\Q-18ILU5;CVAEJVFJLKNW*Q
MTBK25X"NI=6\4892?>6UK+:V`NM@AW/F+;_H[6TV^V-Z8CXK+$9_J;%YDEEO
MKO0#!<:?%FJ"(X6(!.#VY6IO8;;=&L]FN)+N2XO96M!,QA#R^"MM=1HZQVL9
M:LMOJ"#21XDM"!TC>N>A,1N-*+?^_P`Y)ZK(2U^3V_L#$UE=MW9FS:#(UKU<
M$,%!BX\-79O*5#,\]165O,S5+*8K*I/N4O:RRWZQ@YBYUAD6[G+2065M+<6E
MI91/J\,1Q1-`_P!2RO))-.ZQ.TDS:HD>-2#GFGW-NMH:YY9Y/$`M$2..XOIH
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MVMW[@Q5+E/[B5^YH,DVVYJ[;-%`6I3'01$(Q\KA^33D#F+8-N^])NTN]^X^X
MKS#N41B.TR+,\-K<RQ(_T$EP[%)#;*H\%HT"LS$5J&+.<Z\O[WN?W3;&WY?]
MM=K_`*L[1?,XW=)+:*YN[6"5HCN"6QC%P%NG:DNJX>I`\-2N!;XVK2VD@-8Z
M21<!K<$C\@'WT"ZY\]4O9SL?^9)0?++;WQ<INZ_C.,ENCJ7<7<M-N1^F]XMC
M\=AL)N^DVV-O24HWN*FJR4L=<D@E#)%I!N0UE/NO="10_P`Q;9O7'R<^4'3G
MR-[1Z[Z\V]UU+L&FZH?(4-?CLGFI,MM&*OW+4UM3'49&.LA7-D^)1'"88V"D
MOPQT`:9-3^SKQI7'#H$]E_S!ODAV)\=_C))L;%]89'OSY4=[=D]8;3W/FL;G
M*7K;:6S-E93+SG>F4PF.R%5E\O4)MRFIV2".>(322%F"`%#<CA]G7NA<QGRM
M^3W4?8G?WQZ^0*=6;HW[M'XK;W^3'3_:77F+S&(VYF<?M.GR%#78+>NSLSDY
MZRBKJ'/I$R&FJVCJ*5&NR,UUKU[H!MO_`,VS<M3_`"_<WV_DMM8B3Y:XC.+U
M=0];IB,A24.>WS7X5=V83>%)MB>O&<DV96["<9AFBEDB#`0^4!M0W3CU[IP[
M2_F!_(O;O67PFS$F2ZPZCPOR#ZL3=_:/R2WUL#?&Y^J]G;R6D@DI=FKBML5S
MOMF3-RR%XZK)59I8H^&D6Q;WKKW0Y=B?*3Y*=?\`4?QVVKMC=7QZ[M[^^47;
MLG777/:.R*3.0]%8W;0Q5=G*G=^4I*;<&9R>7J\-BL7.TD-)5"*:6P!320V\
M>77NN&(^4?RCZ=[5[;^.WR(;JO>>\:3XQ;W^1W3O:'7&$S.`P=73[/ARM%DM
MK[UVAF,S7U@JZ3,4:2PSTU2B3TRLK!&LWO77NBR];_S1N[MS?#OM;<6\<+M'
M:?RKZHJ.L<^^,J<'50;5WAU9VCNK"TNVM_[>P4V;:JK:&IPN0DAF\56PCJ%$
MGZ&%_=>ZL@^>'R&WY\;OAUV!WCU_!M^?>^`Q&V),7_>2BJJ[!056?RV*QE16
M5=#1UM!430T<=>\H03*/1R2+^_=>Z*;T/\S>]&^3?4W1V]^U?C1\E-K]N]?[
MVWC4[DZ`3(4.9ZGGV=MM=P4[[SC_`+P;FPKX7<3L*.!FF@J/N0UE;25/NO=!
M'\1/YA?:'R&WCU?4[P^5'Q>V-6=@=AY;#O\`'"'K/?%7V.F*I<QEH,?MNCW?
M4;DI\2N;R>)HHZB"L>G:!U8V4M=5W3%>O=&UZD^5_;N]/CA\S>T<RFU/[U]&
M=C]_;9V%'2XFKI<7_">N8:F3;8SM,V0J9JZK_:'W#QO$LA_2%]ZZ]T4_N'Y>
M?.C;OQE^,WRAV?OCHFAVWW3CNCMK9;:F4ZXS^2S-%O?LO(?PS)[@@R%+O-<>
M<'#4UD#)2`^6-$<%V8V%M)+!?/KW0@_)[Y6_*3XQYCXV=/\`8'=?QQVENGM2
MI[5SF_>]]Q=?[KAV!@-O;3IL7+M;#8_:<6YVKDR>0JL@8)IY*ED>1H]*H`Q-
M>O=-O;'SA[FV7\:>B][;$^0/QN[%S7;7R$?JS)=YTVQMR87JS;>W6^Z$LN0P
MF3W;%64>1PM7$(:NIEJ5A`MZ%))][IFG7NI^Q?G;\D:"L^6^P-'2WRRW9T-T
M;1=M["WK\>(\VFV-S;@R%7+1+UIGJ2ER6ZXI-RTJ`5;)053S&!2GC#FXU\_+
MKW2]^$7R5[]^1&8Q>:R/R8^)6_,2M#1U_8G4NU=A[_V5VUU]554U%]SAGPVZ
M]QKEH&QE36''R5%90^!ZD+H9B=)V:>O7NO_2V&=R[%W]28+Y%XO,]"S]9;8V
MQO"E[#V3#TE-'M???8N?PNXJ_$XNDK?/7Y*KW=MV#`9<5M14I!X\?4I(H1E9
MF;EWS)RCS4=H][]GW?VY.R[!'NRW]G%82+%>;DZ3.K0QDM+-=VO@3&\E*1?H
M,%6!4`*+U!Y>YOY1EW7V2N[#W<;?=]N]JDV^_;>U-S8;;;S0)+*]=$:VES]1
M;M;Q(TK/<1%7>35I(,EMKM:JH(J+=S[9WYMK"]I83`;GKLOOOM;$28^+M"A:
M/%4OQ[6//1Y==FR[LI2T]0S0P-(#<LNH6ERTYNW>%)^9X^6KZ#9MSM[6Z7]X
M;M`\'[RAC\`[$BRI(]JERA8R'3$ZI0_IH?#6$-R]O8+]KCED;_M%YO.QW=U:
M*FW;5.)FVMF,S;^)(#";M;62B(IDFIP&NA),WMWY.;)I(9,;5+)(M!65V+AH
M:,4E%F<:V(EQ]-E:2MPF2&$5\1MV>M,7\3I/)1S01!UY)!F+ECW;V':;&SV4
M6+M;PPC0D9BCE@576.2.2"=X"(;9R46X3]*2)5:,-GJ'MX]G^8)I'OD8)K".
M9&URP2B99'A=)X1/IEN!'J-M-IFCD8JV*=->.[#W!VUNS%U<^`_NWL[!5&3I
M:+'UM8\V1DW+38K"5^:S.XLMC9)L=M8;<VON*8X^(A:S^*0EA-XF`]AQN?-V
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MA[%44$NTRK&$>4]K+A0!T`?2VS=T3?-#/9;*=`;/78VT-I3[=V5WG1^+,9*I
MH<3!!C\'-+N:+-5,6:SV7HO)'5--3?>TFDQO)S["7MQRYOMQ]X?>MSN_;*R?
MDRPMO`L=X#+)(5@B6.&8SB1_J+BX34LK-WQ4T]E-)E?W`YCV6V^[/L^TV_NY
M?_UOW&_%S>[$0884:5VDF5;8P*8;>%]+1!9?"EJ'5>K2/>;?6$'15\K\;ZG)
M?,C:?RJ7=L<-)MKHO<'3C[);$%YJNHSN[*/<O]X$S8K4$,=/'1+#]N:=BQ);
M6/I[]U[I-]=?$;'[.^07R;[PSF;PV[(?D!+LU\;MVNVK1^79:[5V\,+,HRU3
M/5R9,9&8>:RI`L=K6)Y]^Z]T6'$_RR\WMCH?I?8FT.])MN=Q?'KNC?'<O5W:
MU+LRBJL53UF]\WELAD=L;@V;79"I@RN`J,;DQ2SH*B-G\09=-R/>R2:?93KW
M2XVE\%^SLYGN[NU?D3WMC^SN[.U>@-S?'7;.6VYL>+:&P^L]D[FI*\UW\&VP
MF2JJS)UE9F*B*JJ)9ZI6?QE%TAKC77ND]M_^57U5BO[C[RR&YLED^X=D?%:?
MXX4VY/L:>/9V2S/]S9=E8_MG(;2E:>IGW=C<-+]M&36Z#3>EKN`X]U[I?S_%
MWY.['Z&Z*Z3Z/[[ZOPU#UGU]2[#WTO9/2M-OG"]@"DHXZ./*TU#+G(9\$0@?
M53,]3#*K:6_K[]U[H'L%_*WJMH_'SK/K[9O>>1VQW1U)WUN+Y';%[5H=GXB7
M;F`WUNLU$.<V[0=>3R-C(.O:F@J6A7&K(NA;Z6`-O?NO=")LSX.=K9O>?:G<
MGR.[YQO9W<N]^B-S_'[9M7M;8D&S]A=;[0W-!D&KZG';>_B%77Y;)UF3JUJ)
MY):E-0UHH`8$>Z]T$'=7\IN#M7JWXR;:Q';YV3V5T/LO9G6>Z]_8W;-0]!VK
MUWM.IQM<FU\[M^//4_CI5R&.\U,99ZCP/(VH/9;>Z]T>#Y>_&>H^47QGW7\?
M*;>";+GW+2[9IEW2^'&:2D&WLOB\FY;%&LHQ.M8F.,9!E&D/?FUC[KW0;;5^
M"^W>K/DG@.^.ELKMWK?"9CJNIZM[MZYQ.SJ.##]CTU&D,NUMS8F2@J:&':FY
M,-7*[331PS"KA8(XXN??+RZ]T#'QJ^$/R@^,]9LC96UN]ND<KT=LK=67R4.+
MRG0L$G:60VWF,UE<S4XRHWW'G8RF8+91HA6",E(E"A=(`]^Z]U$W7_+\[_QD
MW?6P^C/D_B.ON@ODENK<F[=][1W%UG3[MWOM2MWTG@WS2=>;M;+4<%%1YJG+
M"`5E/4-1NQ="6Y]^Z]T-?>'P3Q/8OQGZ0^-.PMX_W$V_TGO#IK/XK+9'#?WA
MJ,EBNJ,MC\C+03TR5V.2+(;@6B;5/J9(99"PC8#3[W4UK7/7NLWRZ^)'8?=_
M9G1W=?3_`&7M/K_L?I.GWWC*&#L#84'8FS,YB=^XVBQM>M;A7K*&6.OH(Z5F
M@D#D!I+V#*I]ZZ]TA]\?"'M/O#KKHC:W>_:766<SO4??,/:^:DV=U%3X#9N\
M-K4L=7'#LF3:51F:FBIIYUJKSUCB42$7,5^??AU[I:=<_"_/]"=@_)?<OQY[
M%P'7&R^^L!1Y;`]>2]?X_*8;K3N6BHWQW]^,,$KJ.GJ=LU])I-1A#%'"TRZE
MD7Z>_=>Z!_8G\OSMS-_);K_Y.?)#O#8^[MX]6TCT^W:;I[J:@ZLAW3,]70SB
M?L>J&1RM9N6"EBI&^V@9]--(X9&`6S>Z]U__T]SWNSH;;E=V-M[Y-R2;XS.Z
M>H<179+#[*VWD)8X-PU5-1U$-/1^'RA4HYDJ6-7`J,M2$4MREFQ>]X_:K;8.
M<MO^\5;)O-]S'RW8$IMEF0WUIB9WB"*QK&X:0^*8_P"UB70P-,Y!>V7NGO%M
MR;O?L@%VN#8.9+A(YKRYC!-NC,FIJTRPTCPG)K&68##8+#M7H`A]G9?;'6V"
MGZ[[9W1D^XN[=C]XY:OW!OG"Y?'0S38Z38F*C,<QK:8:?M)!&Q"Z%DL#?W&F
MT>V\DG]2)]D]OD7D;?+H[UO.U[K-XFY6LZ:S']-!V24%315$C2,RI+VX$L[W
M[M>,G-%IS!SY<Q\\;%MZ[+L5[LD26UA+;N0LOUDM2&C;+25*D]Q3AT_;`ZTP
M>>CZFKMP;BRM2W8FZM_MD<)\A-@H_9.:V%)YI'ZYP59C98Z;;&%IZFDBK*<S
M,)98XU-FY7VIVC8]BWN/VVM>8-ZD6^YCW:^,EIO6W']Y7%C'5SMRM$6$$$31
M+(K2.J5?MHWZ1+^8N;MTV6XY_MMIVB!8-GVW;_"GV"^(VV&_0!?WG,K@FYFE
M21XI0HHC5\NX'#Z]QM",7@<G!EI=VID=U[VH:K)[7P46W=OU=.YK<7_OZL2/
M(F1CPM-MBGQL=6Q+/+''8LK$F:.4)(3!RS=S[C>;E<3[UN$4S[=8&SLGD9)4
M+;I`JGQ!;)$ML+J8@O.!JR0!`/,\S)=[E:#;UL/!V^SDCCNK@W,Z$B*4?22X
M\/QC<-<&("BH6X,.@E[1KY=MIM',U77U;V=NK=46?Z>RVZ>KIJJFI=D;:R&6
M\+PI3+))3TE6IJ[,64,):1@"H%O81YSO[G83R3?[OR')O_.&[-=;))=[(9##
M864[FK,I.E3&I!)904=)*,!0$;\IVT>]Q<SV5KSC'LO+VW&#=X[3<BI>^NX4
M#"C:=3ABA%`2"LJX))/0E?&KX[[?^->R,CLS;FX-Q9^BRVX\EN>0YZ<%*"IR
MC*TE)C:-7ECHH`J#R`.QDENYL3;W(WLI[-;3[)<L7/+.T[W>7\<LYE:2X(K7
M2%`55[%%!G2!J/<U22>@U[S^\>[^]G,EAS/O6S6EG=06,5L!"M"ZQC#2O0%V
MJ2!@:5HHP*]&(]S'U$'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7__U-_CW[KW0%U_^A3_`$_X'[[P_P"G7^Y64_@G_'P>;^YWFB_B7^;_`-^Y
MI\NG_.?O_P"I]PCO_P#K5?Z^W)'[X\;_`%V?W/<_0T^H\+Z34_C:M/\`B^NN
MNGB=]*4_T/J3+#_7&_UJM^^AU?ZV/[TA^I_L*?6:#X/'_&/@K\'Z?\6>HD?^
MF/\`T=[C\/\`"/\`2?\`WCSW]R_[U_PS[3^%_=#[/P?PGTW_`(+Y?'J_=_XZ
M^F_L&\I_\$7_`*U/-'UG@?Z[/]8+KZ+]Y_3?3?0_5KX%?W?_`*!])JTU_P`9
MK77W4Z477^MM_6_9?%^I_J9]%#]5])K\7QO#.NGCXKXNG5^"GP=*C*_Z0_\`
M2YM7['^(_P"CG^Z^7_C_`(/[O?PG^.^4_9_>_=?[^;[K3H\'VO\`D^GR>7G3
M[DB__P!<3_7;Y3\+Q?\`6W_<=Y]9X?TW@_O#Q;;Z?7XG^-T\+Q]'A=E?[3HF
MLOZI_P"M_O7C^!_7#]X1>#J^H\;Z?2=?AZ/\6IJ_M/%[_AT>?39T;_HI_N[N
M+_1'Y/X)_??='\9\O\3U_P!YOXC)_&-/\5_RCP^:WC_'CM?F_LJ]A?\`6?\`
MZFWO^LI7^J?[SN?$K]7J^KU_XQJ^M_QBNO\`BQZ8Z6^YO]?_`-[[3_KA_P#)
M4_=MOX/]C_N+H_1_L>WX>->ZO'H:O<V]1OU[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
3[W[KW7O?NO=>]^Z]U[W[KW7_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
